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Das humane Homolog des murinen Glomerulosklerosegens 
Mpv17 
Zusammenfassung 
Mäuse, homozygot für eine retrovirale Insertion am Mpv 17 Lokus, 
entwickeln Glomerulosklcrosc und ein Nephrotisches Syndrom in 
frühem Alter. Das unterbrochene Gen, das Mpv17-Gen, ist daher ein 
rezessives Glomerulosklerose-Gen in Mäusen. Um herauszufinden, ob 
ein mögliches menschliches Mpv 17 Gen in, humanen Nierenkrankheiten 
eine Rolle spielt, haben wir das menschliche Homolog des Mpv 17 Gens 
isoliert und analysiert. Die Sequenzanalyse ergab, daß das murine und 
das humane Mpv17 Gen hochgradig homolog zueinander sind (92%). 
Unterschiedliche chromosomale Lokalisationen des menschlichen Mpv17 
Gens und des Lokus für das Congenitale Nephrotische Syndrome des 
finnischen Typus, die bekannteste genetische Glomerulosklerose, 
schlossen eine Beteiligung des Mpv17 Gens an dieser Krankheit aus. 
Dies bedeutet, daß das Mpv17 und das putative CNF Gen verschiedene 
Funktionen haben. 
Sowohl das murine als auch das menschliche Mpvl7 Gen kodieren für 
ein 176 Aminosäuren-Protein mit hydrophoben Regionen. Eine 
Computeranalyse ermittelte eine signifikante Homologie zwischen dem 
Mpv 17 Protein und dem peroxisomalen Membranprotein (pmp) 22. Die 
anschließende Immunlokalisierung des Mpv 17 Genprodukts mit 
Antikörpern gegen ein rekombinantes Mpv17 Fusionsprotein ergab eine 
peroxisomale Lokalisation des Mpv17 Proteins. Daher ist das Mpv17-
System eine mögliche Verbindung eines Verlustes einer peroxisomalen 
Funktion und Glomerulosklerose in der Maus. Es gibt jedoch keine 
signifikanten phänotypischen Ähnlichkeiten zwischen den etablierten 
humanen Peroxisomenkrankheiten, wie z.B Zellweger Syndrome (ZS), 
und der Mpv17-mutanten Maus. Deshalb denke ich, daß das Mpv17-Gen 
an einer bisher unbekannten peroxisomalen Funktion beteiligt ist. 
Da Peroxisomen verschiedene enzymatische Aktivitäten besitzen, die den 
intrazellulären Redox-Status kontrollieren, und eine zu hohe Produktion 
von reaktiven Sauerstoff Specien (ROS) mit glomerulären Krankheiten 
in Verbindung gebracht worden ist, haben wir diese Parameter im 
Mpv17-System untersucht. Im Gegensatz zu Wildtypzellen waren 
Fibroblasten, die von homozygoten Mpv 17 Mäusen stammen, 
eingeschränkt in ihrer Fähigkeit ROS zu produzieren. Weiterhin haben 
NIH3T3 Zellen, die das humane Mpv17 Gen konstitutiv 
überexprimieren, (RSV1 und RSV7 Zellen) eine höhere Anzahl von 
ROS als Kontrollzellen, was darauf hindeutet, daß Mpv 17 eine ROS-
produzierende Aktivität besitzt. 
Matrixmetalloproteinase-2 (MMP-2) ist ein Enzym, welches 
möglicherweise am Umsatz der glomerulären Basalmembran beteiligt 
ist. Während es in RSV1 und RSV7 Zellen nicht detektiert werden 
konnte, konnte es problemlos in Mpv17-negativen Zellen nachgewiesen 
werden. Eine Deregulation von MMP-2 in den Glomeruli von Mpv17 
defizienten Mäusen könnte eine Erklärung für die Glomerulosklerose 
sein. Damit übereinstimmend haben immunhistologische Experimente 
gezeigt, daß die Proteinexpression von MMP-2 in MPV17-negativen 
Glomeruli erhöht war. 
Schließlich habe ich demonstriert, daß das menschliche Mpv 17 Gen den 
Nierenphänotyp komplementieren kann, wenn es in die Keimbahn von 
homozygoten Mpv 17 Mäusen eingeführt wird. Daher kann die 
Beteiligung von anderen Genen in der Nähe der proviralen 
Integrationsstelle an der Krankheitsentstehung ausgeschlossen werden. 
Das Experiment zeigt überdies die Funktionalität des humanen Proteins. 
Diese Studien weisen auf eine wichtige Rolle des Mpv 17 Proteins in 
Peroxisomen hin und identifizieren ein wichtiges und neues Gen, das mit 
der Pathogenese von humaner Glomerulosklerose verbunden ist. 
Abstract. 
Mice homozygous for a retroviral insertion at the Mpv 17 locus develop glom-
erulosclerosis and nephrotic syndrome at an early age. The disrupted gene, the 
Mpv17 gene, is therefore a recessive glomerulosclerosis gene in mice. In 
order to determine whether a putative human Mpv17 gene could be involved 
in human kidney disease, we isolated and analysed the human homologue of 
the Mpv17 gene. Sequence analysis revealed that both the murine and the 
human gene are have a high dgree of homology (92%). Different 
chromosomal localisations of the human Mpv17 gene and the locus of 
congenital nephrotic syndrome of the Finnish type (CNF), the mostprominent 
inherited form of glomerulosclerosis, excluded an involvment of the human 
Mpv 17 gene in this condition, suggesting that the Mpv 17 gene is involved in a 
function distinct from the CNF locus. 
Both the human and murine Mpv17 genes can code for a protein of 176 aa 
containing hydrophobic regions. A computer analysis showed a striking homo-
logy to the peroxisomal membrane protein pmp 22. Subsequent immunolo-
calisation of the Mpv 17 protein product using antibodies against recombinant 
Mpv 17 fusion proteins revealed peroxisomal localisation of the Mpv 17 gene 
product. Thus, the Mpv 17 system a likely link between the loss of a 
peroxisomal function and glomerulosclerosis in mice. There are, however, no 
significant phenotypic similarities between well-characterised human 
peroxisomal disorders, such as Zellweger syndrome (ZS) and the Mpv17 
mutant mice. Therefore I believe that the Mpv17 gene is involved in a so far 
unknown peroxisomal function. 
Since peroxisomes possess several enzymes that can contribute to the 
intracellular redox status, and since excess production of reactive oxygen 
species (ROS) has been implicated in glomerular diseases, we investigated these 
parameters in the Mpv 17 system. In cantrast to wild type cells, fibroblasts 
derived from homozygous Mpv 17 animals were found impaired in their ability 
to produce ROS. In addition, NIH3T3 cells constitutively overexpressing the 
human Mpv17 gene (RSV1 and RSV7 cells) show a higher Ievel of ROS than 
control cells, indicating that the Mpv 17 protein has a ROS-producing activity. 
Matrix metalloproteinase-2 (MMP-2), an enzyme potentially involved in the 
turnover of the glomerular basement membrane, could not be detected in the 
RSV1 and RSV7 cells, while in cells negative for Mpv17 expression MMP-2 
transcripts were readily detectable. Deregulation of MMP-2 in glomeruli 
deficient for Mpv17 protein could therefore be a possible explanation for the 
glomerulosclerosis. Consistent with this notion, immunohistological 
experiments revealed that the MMP-2 protein level was indeed increased in 
glomeruli from Mpv17 mutant mice. 
Finally, I showed that the human Mpv17 gene can complement the kidney 
phenotype, when transferred to the germline of homozygous Mpv17 animals. 
This excludes the involvement of genes other than Mpv17 in the vicinity of the 
proviral integration site and further shows the functionality of the human 
protein. These studies indicate that Mpv 17 is an important protein in the 
peroxisome, and identify a potentially important and new gene linked to a 
human kidney pathogenesis. 
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Chapter 1. Introduction. 
The basic function of the kidneys is the detoxification of the blood by 
removing the final waste products of the body's metabolism, such as 
urea, creatine, phosphates, and sulfates. The functional unit of a kidney 
is the nephron. In the nephron the blood is first filtrated and then the 
wanted substances are selectively reaborbed, leaving the waste products 
to be excreted. Furthermore activc removal of waste products takes 
place. There are numerous sites in the kidney where this equilibrium 
between filtration and reabsorption can be impaired, resulting in an 
array of different kidney disorders that often lead to renal failure if left 
untreated. Treatment often consists of dialysis, or transplantation of a 
donor kidney, which are both associated with numerous problems. 
Kidney disease thus poses a major health problern and though today the 
clinician is able to treat many but not all renal defects very little is 
known about their etiology. 
One site of potential pathological changes which leads to serious renal 
defects is the glomerulus. In many cases of glomerular disease the 
integrity of the basement membrane, part of the capillary wall, is 
obstructed giving rise to increased permeability and eventually to 
proteinuria. When this condition is accompanied by an increase in 
extracellular matrix deposition in the glomeruli it is referred to as 
glomerulosclerosis. However, the initial molecular events that cause the 
glomerular lesion as weil as how the different histopathological changes 
in the glomerulus are connected are so far unknown. 
In order to understand and study renal disorders, animal models are 
required. Animal models for human disease produced either by 
external, often chemical, stimuli, by spontaneaus mutations or created 
by transgenesis are valuable tools to study these defects at the molecular 
level within the complexity of a multicellular organism. 
The transgenic mouse strain Mpv17 (Weiher et al., 1990) studied in this 
work is a model for human glomerulosclerosis and nephrotic syndrome. 
While the gene responsible for the Mpv17 phenotype has been isolated 
(Weiher et al., 1990), the molecular mechanism by which it causes renal 
disease is unknown. The aim of my project was therefore to define the 
function of the Mpv17 gene productat the cellular and molecular level. 
This should then permit possible diagnostic and therapeutic approaches 
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to the treatment of human renal disease to be developed. In this 
introduction I will describe the physiology and function of the kidney, 
and survey the pathology of kidney diseases, with particular reference to 
the Mpv17 model. Finally, I will summarise the aims of my project. 
General function of the kidney 
Removing waste products from the body and controlling the 
concentrations of several ionic substances such as sodium, potassium as 
weil as the pH value in the extracellular fluid is the principle function of 
the kidneys. The amount of extracellular fluid in a human body is 
around 15 1 and is the sum of blood plasma (3 1) and the so called 
interstitial fluid (12 1) which is the fluid in the spaces between the cells 
(Guyton, 1984). There is a ready exchange among these two systems 
through pores in the capillary membranes. In this way nutrients are 
transported from the blood system to the cells and excreted waste 
products are transported in the other direction. As these often toxic 
excreta are collected in the blood the body needs ways to get rid of these 
substances without having to exchange the complete volume of the 
extracellular fluid. 
Kidney anatomy 
In most mammals the kidney is normally supplied by a singl~ renal 
artery that enters the hilar region (hilus), which is a slit located on the 
concave side of each kidney. This main stem artery divides to form a 
anterior and a posterior branch from which smaller arteries arise. These 
supply the lower, middle, and upper parts of the anterior segment of the 
kidney, and also the posterior half, which is divided into apical, 
posterior, and lower segments, respectively. The renal pelvis, vein, the 
lymphatics and a nerve plexus also pass into the kidney via the hilar 
region. A bisected kidney reveals two distinct regions: a pale outer 
region called the cortex and a darker inner section, the medulla. In 
humans, the medulla is divided into between 8 to 18 so called renal 
pyramids with each apex extending towards the renal pelvis forming a 
papilla. In rats and mice only a single pyramide can be found, which is 
called a unipapillate kidney. The base of each pyramid is located at the 
boundary of the cortex and the medulla. Despite this slight difference, 
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the rodent kidney resembles the human organ in its appearance. A tough 
fibrous capsule surrounds the kidney on the outside. 
Development of the kidney 
During embryogenesis three distinct stages of the developing kidneys 
are defined: the pronephros, the mesonephros, and the metanephros. All 
three forms originate from the nephrogenic cord, which is of 
mesodermal derivation. The pronephros dcvelops in the human embryo 
at the end of the third week after conception. It is composed of seven 
tubules that form nephrostomes at their proximal ends and open into the 
coelomic duct. The distal ends create the pronephric duct, that finally 
empties in the cloaca. It is however thought that the pronephros in 
mammals is not yet a functional unit, but is just a precursor of the later 
stages of kidney development. During the middle of the fourth week the 
mesonephros starts to develop, which contains more nephrons than its 
predecessor. At this stage, glomerular structures begin to appear as part 
of the mesonephric tubule, that ends in the the mesonephric duct. In the 
male the mesonephric tubules and the mesonephric duct form several 
components of the reproductive system later on, while in the female the 
mesonephros mainly regresses. The final developmental stage of the 
mammalian kidney is the metanephros. While the excretory portion 
including the collecting ducts, calyces, pelvis, and ureter develops from 
an outgrowth of the mesonephric duct called the ureteric bud, the renal 
corpsule is formed from the metanephric blastema in the nephrogenic 
cord. The kidney of a new-born baby contains nephrons of different 
developmental stages that mature with time, but new nephrons are not 
created. At birth the most mature nephrons are located near the 
medulla, while the the less developed nephrons are seen in the outer 
cortex. lt is thought that nephrons in the growing metanephros start 
functioning around the 11th week after conception. The post-natal 
maturation process is indicated by a dramatic increase of the glomerular 
filtrationrate (GFR) from 0.045 ml/minlg kidney weight ig1-3-day-old 
rats to 1.0 ml/minlg kidney weight in 40-day-old rats, which is due to 
the enlargment of the endothelial pores and the epithelial slit area. 
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Kidney Physiology 
The principle functional units of the kidney are the two million 
nephrons in the two kidneys of humans. Rodents only possess around 
70,000 nephrons. lt is essential to understand the structure and function 
of a nephron in order to conceive the events leading to renal defects. A 
nephron consists of the renal corpuscle that itself is composed of the 
glomerulus, a network of capillaries, and the Bowman" s capsule 
surrounding the glomerulus, and tubules being subdivided into the 
proximal part, the loop of Henle, the distal tubule, the collecting duct 
and the pelvis (Figure l.la). Since the blood pressure in the glomerulus 
is as high as 60 mm Hg compared to 30 mm Hg at the arterial end of an 
average capillary it is possible to passage large quantities of fluid 
through the glomerular capillary wall. This fluid is called the 
glomerular filtrate and contains most of the waste products but also 
essential ions, sugars and other small molecules. The glomerular filtrate 
is passed into the Bowman" s capsule (space) from where it is 
transported to the tubular system. As the filtrate passes through these 
tubules, substances elementary to the body such as glucose, amino acids, 
certain ions, and a large volume of water are reabsorbed by the 
peritubular capillaries, that entwine the tubular system. This 
reabsorbtion occurs in a selective manner leaving most of the waste 
substances behind, which are passed on through the collective duct < nd 
pelvis into the ureter. By this way more than 180 litre of glomerular 
filtrate is produced each day, but due to the reabsorbtion process only 
1.5 litre leave the body in form of urine and need to be replaced. Hence, 
the waste products being composed of mainly urea, uric acid, creatinine, 
phosphates, sulfates and certain acids are excreted in a rather 
concentrated form in the urine that is finally passed on from the ureter 
to the bladder. The basic function of the nephron can therefore be 
summarised as a two step process: (1) A large amount of plasma is 
filtered through the glomerular membranes, thereby clearing the blood 
from unwanted products and (2) in the tubular system the substances 
which have been passed through the filter together with the obsolete 
waste products, but which are still required, are selectively reabsorbed 
into the blood system. During this second process a few substances that 
have failed · to be cleared from the blood are actively removed by 
secretion through the tubular walls. Hence, the urine is formed by a 
a 
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combination of filtration and secretion processes. In glomerular diseases 
the filtration process is impaired for numerous different reasons often 
leading to renal failure. 
vein 
Descending or 
thin !oop of Henle 
b 
Collecting tubule 
Capillary endothelial cell 
I 
: Basement membrane 
I I 
1 : Epithelial cell 
\ ~ : 
,.--'----, r--'-, ,----"-----, 
\j·~c~_ .. 
··o-~c~ 
PLASMA '• 0 . FILTRATE 
~:o~ 
Fenestra~o·· :,; ,~ a--'7 
'·{·~~ 
'--- Slit-pore 
Figure 1.1 a: The functional nephron. b: Functional structure of the glomerular 
membrane (both taken from Guyton: Physiology of the Human Body. Saunders 
College Publishing, Philadelphia, 1981) 
Cellular and molecular composition of the glomerulus 
The filtration step is accomplished by the glomerular membrane that is 
comprised of a layer of endothelial cells of the capillary itself, a 
basement membrane composed of collagenaus and proteoglycan fibers, 
and an epithelial celllayer on the other side (Figure 1.1 b ). 
However, these cell layers do not form an impermeable layer, but are 
interrupted by openings called fenestrae in case of the endothelial cell 
layer and by slit pores between the adjacent foot processes of the 
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epithelial cells. The basement membrane between the two layers is also 
highly porous because it is a meshwork of fibers. Therefore, it is 
thought that the fenestrae, the slit pores, and the spaces between the 
fibers tagether constitute the filtration barrier between capillary blood 
and the urine space, also called Bowman/ s space. The collagenaus fibers 
of the glomerular basement membrane, a specialized extracellular 
matrix, consist mainly of members of the type IV collagen family. This 
family so far includcs six different a chains: a 1 (IV), a2 (IV), a3 
(IV), a4 (IV), a5 (IV), and a6 (IV) (Hudson et al., 1994). It is known 
that mutations in the a5 (IV) chain are involved in the etiology of 
Alport syndrome a familial kidney disease associated with sensory 
neural deafness (Barker et al., 1990). Recently mutations in the a3 (IV) 
and a4 (IV) chains have been shown to play a causative role in non X-
linked Alport syndrome (Mochizuki et al., 1994) indicating that genes 
coding for the proteins comprising the GBM are all candidate genes for 
inherited glomerular disease. Goodpasture syndrome, an autoimmune 
disease also characterized by glomerulonephritis, is caused by 
generation of antihoclies directed against the collagen a3 (IV) gene 
product (Sauset al., 1988). The structural homology among the six type 
IV collagen chains is charaterized by a 230 amino acid long non-
collagenaus domain at the carboxyl terminus, and a 1400 residues long 
stretch of Gly-X-Y repeats being designated the collagenaus domain, 
that is interrupted at different sites by variable sequences. Three a 
chains are joined tagether to form a triple-helical structure, a so called 
protomer, that can differ with respect to the type and stoichiometry of 
chains thereby confering a high level of diversity on the protomeric 
structure. Protomers themselves can interact with each other in either a 
head to head or tail to tail fashion resulting in the collagenaus meshwork 
of the GBM. The reason for the existence of at least six different type 
collagen chains in the GBM is still unknown, but raises questions about 
their possible involvement in kidney disorders other than those already 
described. An abnormal synthesis of collagen type IV is often found in 
polycystic kidney disease or glomerulosclerosis. In addition to collagen 
IV, the major structural component of the GBM, laminin, nidogen, and 
proteoglycans are bound into the collagen meshwork in an unknown 
manner. The heparan sulfate proteoglycan is believed to repel large 
proteins with its high anionic charge and interestingly its synthesis is 
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upregulated in glomerulosclerosis, as are collagen IV and laminin. On 
the electron microscopic Ievei three layers can be distinguished in the 
GBM. In the centreis a dense layer, the Iamina densa, that is enclosed 
by the Iamina rara externa and the Iamina rara interna. This layered 
appearance is due to the fusion of the endothelial and epithelial basement 
membrane during development (Abrahamson et al., 1985). Negatively 
charged glycosaminoglycans have been found in all three layers of the 
GBM, constituting a charge selective barrier in addition to the size-
selectivness established by the collagenous meshwork. Removal of these 
sugar residues by enzymatic digestions resulted in an increased 
permeability of the GBM to serum albumin for example, that is 
normally not able to pass through glomerular capillary wall, suggesting 
a possible role of the glycosaminoglycans in establishing the 
permeability characteristics of the GBM (Glassock et al., 1991). Usually 
proteins of the size of albumin or bigger are almost completely 
restricted from being passed on into the urinary space. It is commonly 
believed that the GBM is the principle structure responsible for the 
permeabilty properties of the glomerulus, although the other 
constituents certainly have their role in the filtration process either 
actively or indirectly by maintaining the integrity of the GBM. 
The visceral epithelial cells or podocytes are the largest cells in the 
glomerulus. They form long multiple processes called foot processes 
outward from the main cell body that wrap around individual capillary 
loops. These pedicels come into direct contact with the lamina rara 
extema of the GBM. The part of the membrane of the podocytes that is 
attached to the GBM is referred to as the basal cell membrane while the 
domain facing the urinary space, which is by far the majority of the 
podocyte" s surface, is called the luminal membrane. The attachment to 
the GBM is thought to be facilitated by integrin molecules. Immuno-
chemical studies have revealed the presence of ß 1-integrin and 
corresponding a 3 chains on the basal membrane. However, the adhesion 
mechnism through this particular integrin cannot be the sole one, as 
experiments using peptides competing for binding to the RGD site 
(Ruoslathi et al., 1986) on the GBM do not impair the attachment of the 
cells to the matrix. 
Since the podocytes on the one side face the urinary space and on the 
other side adhere to the basement membrane, the two sides require 
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different biochemical and biophysical properties. This polarisation, a 
common feature of epithelial cells, is usually created by tight junctions 
(Farquhar et al., 1963), but glomerular epithelial cells employ a 
different method to achieve the separation of the luminal from the basal 
side. The gap between two adjacent foot processes forms the filtration 
slit or slit pore that is spanned by a thin membrane, the slit diaphragm 
(Rodewald et al., 1974). It is thought to be involved in the permea-
selcctivc filtration process. A prominent feature of the podocytes is the 
presence of a negatively charged surface coat of the membrane due to 
numerous sialic acid residues on the plasma membrane of the pedicels. 
The major protein carrying these negtively charged sugar moieties has 
been identified as a 140 kd sialoglycoprotein in rats (humans form a 
doublet of 160 and 170 kD) named podocalyxin (Kerjaschki et al., 
1984). It could be shown that in an experimental rat model for human 
glomerular minimal change nephropathy, generated by intoxification 
with puromycin aminonucleoside, the amount of sialic acid residues was 
reduced by about 75 %, while the number of podocalyxin molecules was 
unchanged, suggesting a loss of sialic acid rather than down regulation 
of protein synthesis is causative for the drop in negative charge on the 
surface of the podocytes of the treated rats (Kerjaschki et al., 1985). 
The dramatic decrease in the number of sialic acid residues was 
associated with a flattening of the foot processes, typical for several 
glomerular lesions (Mostofi et al., 1971). Interestingly, the same 
phenotype could be observed when rat kidneys were perfused with 
medium containing polycationic compounds (e.g. poly-L-lysine) being 
capable of neutralizing the anionic character of the visceral epithelial 
cells, suggesting a causative role of the loss of negative charge for the 
morphological changes of the podocytes (Seiler et al., 1975). The 
question of whether this flattening of the podocytes is the primary defect 
leading to the dysfunction of the epithelial cells and thereby eventually 
to the glomerular disease is still open. However, it is commonly 
accepted that the collapse of the normal shape of the podocytes is not 
due to a passive loss of the negative surface charge, but is an active 
process involving complex cellular activities as a response to the 
treatment with poly-L-lysine, for example. Other antigens that have 
been identified on the surface of visceral epithelial cells are the 
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Heymann nephritis antigen (gp 330) and the human glomerular C3b 
receptor (Kerjaschki et al., 1992). 
There is evidence that pododcytes are at least one site of the synthesis 
and maintenance of the GBM. Cultured human visceral epithelial cells 
have been found to produce type IV collagen and glycosaminoglycan 
synthesis has been detected in cultures of rat podocytes. In addition, 
certain prostaglandins can be synthesised by cultured epithelial cells. A 
subtype of these glomerular cells arc the parietal epithelial cells which 
line the outer wall of the Bowman~s capsule and form a continuous 
epithelium with the podocytes. 
The glomerular capillaries are confined by: a thin endothelium, thereby 
forming the initial barrier that substances from the capillary Iumen have 
to pass before they encounter the fibrous network of the basement 
membrane and finally the layer of epithelial cells on their passage to the 
Bowman ~ s space. The endothelium is perforated by pores called 
fenestrae, which have diameter of around 100 nm in the human kidney. 
Thin diaphragms have been observed spanning these fenestrae. As for 
the podocytes, the negative charged glycoprotein podocalyxin has been 
identified on the surface of the glomerular endothelial cells, giving the 
membrane an overall anionic character. This also contributes to the 
charge selective properties of the filtration apparatus. 
A third cellular component of the glomerulus are the mesangial cells 
which together with the surrounding matrix material make up the 
mesangium. The matrix is similar but not identical to the glomerular 
basement membrane. It contains sulfated glycosaminoglycans, 
fibronectin, and laminin. The mesangial cell is irregular in shape, 
possesses a dense nucleus and elongated cytoplasmic processes. It is 
thought that mesangial cells are specialized pericytes having the 
functional properties of smooth muscle cells. In addition to the 
structural support they give to the capillary loops in the glomerulus, 
they might be involved in the control glomerular filtration by regulating 
the blood flow in the glomerular capillaries with their contractile 
properties. Stimulation of contraction by various substances such as 
angiotensin II, vasopressin, and platelet-activating factor (P AF) of 
mesangial cells in culture have been observed, as well as a relaxant 
reaction in response to agents like prostaglandin E2 (PGE2). The latter 
can be produced by mesangial cells themselves thereby counteracting 
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and regulating the vasoactive substances, atrial peptides (ANP), and 
dopamine. In addition, mesangial cells are thought to possess 
phagocytotic properties. The prostaglandin production can influence the 
local cell proliferation and the production of cytokines, which are 
known to be involved in glomerular diseases. Therefore, the study of 
the interactions between cytokines, glomerular cells, and prostaglandins 
is important in order to understand the mechanisms of such disorders. 
The different entities of glomerular disease as well as their etiology will 
be introduced in the next section. (The general anatomy and phyiology 
of the kidney is discussed in depth in Tisher and Madsen, 1991 and 
Guyton, 1984.) 
Glomerular diseases 
Kidney diseases can be subdivided into seven classes including vascular 
diseases, glomerular diseases, tubular disorders, interstitial diseases, 
cystic kidney diseases, renal disease as part of multi-system disease, and 
nephrothialises. A simplified classification of glomerular diseases is to 
distinguish between glomerulosclerosis and glomerulonephritis. 
Glomerulosclerosis in children usually has a bad prognosis and due to 
the lack of adequate therapeutic treatment often requires a kidney graft 
in the last instance (Müller-Wiefel and Waldherr, 1992). A study 
collecting data of four years from 73 pediatric transplantation centers in 
the US revealed that glomerulosclerosis is the second most common 
reason leading to kidney transplantation (McEnery et al., 1992). Overall 
200 transplantation cases in this study were ascribed to 
glomerulosclerosis, indicating that it is a relatively rare disease. Besides 
these congenital and infantile diseases, the importance of 
glomerulosclerosis arises from its appearance in connection with various 
kidney and multi-organic diseases. 
Glomerular defects frequently give rise to the nephrotic syndrome 
which can have multiple causes and are characterized firstly by massive 
proteinuria often associated by lipidurea, hypoalbuminemia and 
hyperlipidemia. 
Glomerulosclerosis and nephrotic syndrome are not single disease 
entities having a defined etiology or a clear cut pathological picture. The 
nomenclature and classification of glomerular diseases is complex and 
often deals with several synonyms for the same clinical condition. 
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Differences between distinct pathological entities are sometimes very 
subtle and hard to define. 
First of all I will discuss the different causes for the nephrotic 
syndrome. The literature subsumes different scleroses and nephritises 
leading to the nephrotic syndrome in the absence of any underlying 
inherited, multisystem disease (e.g. diabetes or AIDS), drug, or 
microbial exposure. The definitions of primary gomerular diseases that 
evoke the nephrotic syndrome or ideopathic ncphrotic syndrome (INS) 
have been introduced for this group in the Iiterature (Glassock et al., 
1991). The second group sums up specific etiologic events and disorders 
in which glomerular lesions arise secondary to other diseases leading to 
the nephrotic syndrome. The kidney phenotype in this group is a 
consequence of medication or intoxification (e.g. contrast media, 
interferon, and heroine abuse), allergens, immunisations, infections (e.g. 
hepatitis B, HIV-1), neoplastic changes (e.g., leukemia, Iymphomas, and 
solid tumors), multisystem diseases (e.g. rheumatoid arthritis, 
Goodpasture's syndrome), and heredofamilial and metabolic diseases 
(e.g. diabetes mellitus, Alport"s syndrome, congenital nephrotic 
syndrome). This group also include glomerular lesions resulting from 
chronic renal allograft rejections or pregnancy. (Fora complete list see 
Glassocket al., 1991). 
Very little is known about the etiology of INS. However, much 
knowledge has been accumulated regarding its morphology and 
pathogenesis, making it possible to classify idiopathic nephrotic 
syndrome into several groups of clinicopathological entities. These are 
minimal-ehange disease, mesangial proliferative glomerulonephritis, 
focal (and segmental) glomerulosclerosis, diffuse glomerular sclerosis, 
membranaus glomerulonephritis, mesangiocapillary glomerulonephritis, 
endocapillary proliferative glomerulonephritis, other chronic, 
sclerosing lesions, and other unclassified lesions. This classification is 
based on light microscopic examinations of renal biopsis complemented 
by immunofluorescence and electron microscopic studies. It is also 
possible that one or more members of this group now being viewed as 
discrete entities are in fact heterogeneaus disorders and the classification 
must be regarded as being in a constant state of development. Focal and 
segmental glomerulosclerosis is, for example, frequently found to be 
superimposed on minimal change disease, mesangial proliferative 
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glomerulonephritis and sometimes on other primary glomerular lesions 
(e.g. IgA nephropathy), and the pathological differences are often so 
subtle that even in the clinical practice it is sometimes difficult to 
distinguish between these entities. 
Minimal change disease is the dominant primary glomerular condition 
in children (83%) thereby often resembling the characteristics of a 
congenital (birth to 3 months of age in humans) or infantile (3 months 
to one year of age) ncphrotic syndrome. The minimal change disease, 
also called minimal change lesion, minimal change nephropathy, or by 
its old name lipoid nephrosis due to lipid droplets in the cells of the 
proximal tubules, was first described by Munk (1913). The lesions in 
the tubules are accompanied by heavy proteinuria, but no abnormalities 
of the glomeruli, i.e. hyaline material deposits can be seen by light 
microscopy. However, when these glomeruli are examined by electron 
microscopy it is found that the visceral epithelial cells are affected. The 
foot processes are fused, leading to closing of the slit-pores. However 
there is normally no detachment of the podocytes from the basement 
membrane, which is usually of normal thickness. This parameter 
discriminates between minimal change disease and focal and segmental 
glomerulosclerosis. Another marked difference between these two 
conditions is the presence of IgM and complement depositions in focal 
and segmental glomerulosclerosis, which are thought to be due to 
unspecific trapping of immunglobulins leading to subsequent binding of 
complement substrates in the glomeruli. No distinct mesangial 
hypercellularity has been observed for both conditions. This again 
distinguishes them from the third clinicopathological condition of this 
group which can also be sometimes superimposed by a focal and 
segmental glomerulosclerosis which is termed mesangial proliferative 
glomerulonephritis. The latter is a relatively uncommon glomerular 
lesion being found in less than 10% of patients with idiopathic nephrotic 
syndrome. In uncomplicated cases of mesangial proliferative 
glomerulonephritis no segmental sclerosis can be detected, but IgM 
deposits have been observed. The epithelial foot processes are also 
diffusely swollen (fusion) and the basement membrane is sometimes 
found to be slightly enlarged (Glassock et al., 1991). Two other 
differences between minimal change disease and glomeruloscleroses are 
that patients suffering from the latter often fail to respond to treatment 
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with corticosteroids and that spontaneaus remissons are frequently seen 
in minimal change patients, but rarely found in glomerulosclerosis 
cases. Glomerulanephrites include an inflammatory element and will not 
be further discussed even though they also exibit glomerulosclerotic 
characteristics. Thus glomerulosclerosis is the major common feature of 
renal defects associated with nephrotic syndrome. 
So far quite, a few general etiologic factors leading to 
glomerulosclerosis have been suggested. Gonzalcz-Rubio (1992) report 
on the role of oxidative stress in the development of glomerulosclerosis, 
while Diamond and Kamovsky (1992) see accumulating evidence for the 
involvement of hypercholesterolaemia as one of the major features of 
glomerulosclerosis in the initial glomerular injury. In a study by 
Kasiske et al. (1990), with rats fed a high-cholesterol diet and 
developing glomerular lesions, a relative increase in cholesteryl esters 
was the principal alteration in the major Iipid classes in the kidneys of 
these animals. How cholesteryl ester accumulation might lead to renal 
injury is unclear. In another experiment feeding rats a cholesterol-rich 
diet over a short term led to an increase in the glomerular capillary 
pressure and a decrease in the glomerular filtration rate (Kaplan et al., 
1990). These effects were prevented by adding an antioxidant to the 
diet. The authors therefore concluded that native low density Iipoprotein 
(LDL) oxidised in vivo initiates events leading to vasoconstriction and, 
postulated that these abnormalities contribute to progressive 
glomerulosclerosis. Another potential effect of oxidised LDL is direct 
mesangial cell injury (Keane, et al., 1990). Furthermore, it is 
hypothesised that oxidised LDL might be involved in the increased 
recruitment of circulating monocytes into the glomerulus (Diamond and 
Karnovsky, 1990) leading to elaboration of peptide mitogens or to the 
perturbation of the glomerular eicosanoid balance, which could thereby 
lead to glomerulosclerosis. lt is known that certain cytokines and growth 
factors are upregulated in glomerular disease (Sedor, 1992 and Floege 
et al., 1993). Recently Imai et al., (1994) showed that kidney specific 
overexpression of TGF-ß and PDGF-ß in rats led to glomerulosclerosis. 
Other factors that have been reported to lead to glomerulosclerosis are 
physical force, such as lasting hypertension (Neuringer et al., 1992; 
Kaplan, et al., 1990) or increasing tension in the capillary wall and or 
stretching of the mesangial cells (Riser et al., 1992). Kritz et al. (1994) 
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report that the GBM expands in response to an increase in the 
hydrostatic pressure gradient across the capillary wall, and that the 
contractile system of the podocytes formed by microfilament bundles 
counteracts this pressure-dependent dilation of the glomerular capillary 
wall. Podocytes possess receptors for various vasoactive substances 
including endothelin (Rebibou et al., 1992; Hori et al., 1992), 
angiotensin II (Yamada et al., 1990), and ANP (Sharma et al., 1992). 
Any alterations in the cytoskeletal apparatus could impair the response 
to these substances, potentially leading to glomerular injury. Additional 
elements that are associated with the development of glomerulosclerosis 
are vascular injury (Klahr et al., 1986) and continual immunological 
injury of glomeruli (Wilson, 1991). In the case of diabetic nephropathy, 
which is the leading cause of endstagerenal failure in the United States 
(Kashgarian et al., 1994), it is suspected that nonenzymatic 
glycosylation of proteins due to the hyperglycemia (Crowley et al., 
1991; Flier and Underhill, 1988; Skolnik et al., 1991) Ieads to an 
increase in the normal GBM components. This effect is mediated by 
receptors for the so called advanced glycosylation end products on 
macrophages and mesangial cells which elicit a series of intacellular 
signaHing events. 
Glomerulosclerosis is considered to be the final common pathway 
leading to end-stage kidney disease caused by various initial events. The 
understanding of the mechanisms involved in this development is 
regarded to be of primary importance in order to be able to interfere 
with the progression of the renal disease. At which stage of this final 
common pathway the different factors intervene and whether there is 
one factor to which they can all be reduced remains an open question. 
The genetic kidney diseases giving rise to the nephrotic syndrome in 
young children are among the best defined pathological entities. The 
congenitial nephrotic syndrome of the Finnish type (CNF) is a disease 
very frequent in Finland. A familial history has been descibed for most 
cases and an autosomal recessive transmission has been established for 
them. It is characterised by dilations of the proximal tubules and focal 
and segmental glomerulosclerosis (Norio and Rapola, 1989). Habib and 
Bois (1973) first introduced the condition called diffuse mesangial 
sclerosis (DMS) and have so far reported 30 cases, of which 30% were 
familial (Habib et al., 1993). While the phenotype of DMS is similar to 
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CNF in many respects, it differs in its rapid progression to end-stage 
renal failure and the hypertrophy of mesangial cells. Interestingly, DMS 
resembles the nephropathy seen in a subset of Drash syndrome and 
Wilm" s tumor (WT) patients (Habib et al., 1989). Norio and Rapola 
(1989) speculate about numerous other familial cases of congenitial and 
infantile nephrotic syndromes that are not classified in any of the main 
conditions, because of their isolated occurence. In the already mentioned 
Alport syndrome, mutations in the gcncs for collagen type IV cause the 
nephrotic syndrome and hematuria. 
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Animal models for kidney disease 
Recently a gene for dominant autosomal polycystic kidney disease (The 
European Polycystic Kidney Disease Consortium, 1994) and one 
responsible for tubular sclerosis (European Chromosome 16 Tubular 
Sclerosis Consortium, 1993) have been cloned. The functions of the 
respective normal proteins as well as the mutated forms are at present 
unknown. ModeHing the diseases in mice is a way to elucidate the 
mechanisms leading to the renal failure. Other kidney diseases that await 
the generation of animal models are the Alport syndrome and, as soon 
as the particular gene for it has been identified, Finnish N ephropathy 
(CNF). The biochemical events that have been identified as being 
involved in kidney disease can also be imitated by transgenesis, i.e. 
over-/ecotopic expression or elimination of genes coding or controlling 
these factors. Other transgenic mouse lines have been found incidentally 
to develop disorders of the kidney. The following list shows transgenic 
mouse strain that develop glomerulosclerosis or exhibit abnormalities 
that are found in connection with it. 
Inlillig=en=e~----------~s~p=e=ci=es~--~---------=re=n=al~l=es=io=n~------
SV 40 large T antigen 
c-myc 
ll-6 
Renin 
Pax-2 
HIV -1 genome 
TGF-ß, PDGF-ß 
(gene transfer) 
mouse 
mouse 
mouse 
rat 
mouse 
mouse 
rat 
glomerulosclerosis,cysts 
glomerulosclerosis,cysts 
mesangial proliferation 
glomerulosclerosis 
glomerulosclerosis 
glomerulosclerosis 
glomerulosclerosis 
Figure 1.2 Glomerular lesions in transgenic animals (ref.: MacKay et al., 1987; 
Trudelet al., 1991; Suematsu et al., 1989; Bachmannet al., 1992; Doi et al., 1988; 
Dressler et al., 1993; Koppet al., 1992). 
Mice that carried the viral oncogene SV 40 large T antigen under the 
control of its own enhancer elements died at an early age from choroid 
plexus ependymoma (brain tumor). The transgenewas expressed in the 
tumors, and at lower Ievels in kidney tubules and thymus. In accordance 
with this finding the tubular epithelial cells of the animals underwent 
proliferation leading to cystic dilatations. Though not expressed in 
glomerular cells, the transgene caused glomerulosclerosis with 
increasing proteinuria and nonspecific IgG deposits. 
17 
The transgenic mouse line ecotopically expressing the c-myc gene in 
renal tubular cells, using the same control elements as in the first 
example, emphasises the point that defective regulation of epithelial cell 
growth is involved in the development of cystic kidney disease and 
possibly in the development of glomerulosclerosis, although the latter 
could be a secondary effect due to the the tubular changes. 
Interleukin-6 (11-6) is a pleiotropic cytokine that is also a growth factor 
for mesangial cells. Overexpression of human Il-6 in B-cclls resulted in 
plasmacytosis and hyperproliferation of mesangial cells in transgenic 
mice. When the same gene was hooked up to the mouse metallothionein-
1 gene promoter, the kidney phenotype was more severe. The initial 
membranous glomerulonephritis was followed by focal 
glomerulosclerosis and finally extensive tubular damage. 
A transgenic rat model overexpressing the mouse renin gene showed 
severe hypertension and glomerulosclerosis. This demonstrated the 
importance of arterial blood pressure control for normal glomerular 
function. Thus, renin that is secreted by the kidneys acts on the plasma 
protein angiotensinogen, eventually resulting in an activation of 
angiotensin that increases the blood pressure. 
Pax-2 is a transcription factorthat is thought tobe implicated in normal 
kidney development and in the development of Wilms tumor. Dressler 
et al. (1993) deregulated the expression of the mouse Pax-2 gene and 
produced a dominant gain-of-function mutation in transgenic mice. The 
transgene was expressed in heart, liver, lung, lung, pancreas, and gut, 
while the endogenous gene was only expressed in kidney and hindbrain. 
The kidneys of the mutant mice exhibited microcystic tubular dilatation, 
loss of foot processes and poorly developed endothelial fenestrae. These 
histological findings and the proteinuria resemble the Finnish 
Nephropathy, suggesting that Pax-2 is involved in CNF. 
The transgenic mouse strain bearing a 7.4 kb long transgene containing 
the HIV-I genes env, tat, nef, rev, vif, vpr, and vpu, but lacking the gag 
and pol genes, developed focal and segmental glomerulosclerosis, that 
closely resembled the renal syndrome seen in AIDS patients. 
TG F- ß and PDGF are known to participate in the process of 
accumulation of ECM that is a central biological feature of 
glomerulosclerosis. Both growth hormones were found to be 
overexpressed in experimental models for glomerulosclerosis and the 
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excessive matrix production could be stopped by injecting anti-TGF-ß 
serum into the animals (Okuda et al., 1990). Imai et al. (1994) 
transfected PDGF and TGF-ß into rat kidneys in vivo by transfer of 
expression constructs containing an actin promoter and the two 
respective human cDNAs. The pathological changes of the TGF-ß 
transfected rats consisted of a moderate increase of mesangial cell 
proliferation and an extensive ECM expansion. The PDGF transfected 
rats exhibited a slightly different phenotype. However, in both animals 
the onset of glomerulosclerosis occured within a short period after the 
transfection. 
All these models for glomerulosclerosis include the accumulation of 
extracellular matrix that eventually Ieads to proteinuria and end-stage 
renal failure, regardless whether the initial stimulus to injury was 
immunological, hemodynamic or metabolic. They help to elucidate the 
final common pathway leading to glomerulosclerosis by defining the 
different factors involved. 
The Mpv17 Mouse: a model for human kidney disease 
The Mpv17 mouse strain is a recessive transgenic mouse mutant that 
develops glomerulosclerosis and nephrotic syndrome at young age 
(Weiher et al., 1990). This transgenic line was generated by infection of 
CFW mouse embryos with the recombinant retrovirus MPSVneo 
(Seliger et al. 1986; Weiher et al. 1987). The virus, a derivative of the 
myeloproliferative sarcoma virus, which is an ecotropic murine RNA 
tumor virus related to Moloney murine leukemia virus, was not able to 
replicate, and carried a neo gene as a reporter. As a retrovirus it 
integrates into the genome of its host and could thereby lead to 
activation or repression of certain genes, possibly giving rise to 
dominant (e.g. gain of function) or recessive (gene inactivation) 
phenotypes. This process is called insertional mutagenesis. After having 
been exposed to virus producing cells, 4-16 cell CFW mouse embryos 
were transferred to pseudopregnant foster mothers. The resulting 
mosaic founder animals were bred until germline transmission of the 
retroviral insert was observed. The created transgenic lines were 
screened for single copy integration. None of these animals expressed 
the transgene or exhibited a dominant phenotype. The mice possessing 
only a single proviral integration were bred to homozygosity for the 
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insert. Two of these mutants resulted in recessive lethal phenotypes, of 
which one was the Mpv17 mouse. The Mpv17 animals exhibited no 
apparent phenotype up to the age of two or three months of age. At this 
time they began to develop pallor, weight loss and showed a generally 
reduced activity. Subsequent serum analysis of the diseased animals 
demonstrated that pathological changes already began at the age of six to 
eight weeks. These included elevated cholesterollevels as one of the first 
signs, and increased blood urea nitrogen and creatinine levels. Albumin 
levels were reduced due to the proteinuria and finally a decreased red 
blood cell count, low hematocrit, and reduced hemoglobin levels could 
be measured. The massive proteinuria and other abnormalities were 
indicative of renal failure and were characteristic of the nephrotic 
syndrome in man (for an account on the nephrotic sydrome see the 
section on kidney diseases). The survival times of individual mice varied 
between six weeks and one year. Figure 1.3 (taken from Weiher et al., 
1990) depicts a comparison of wild type, Mpv17 heterozygous animals 
and Mpv17 homozygous animals and shows that only animals 
homozygous for the retroviral insert at the Mpv17 locus eventually died 
from renal failure (Figure 1.3), while wild type and heterozygous 
animals are indistinguishable, which was also true for the physiological 
parameters listed in Figure 1.3. 
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wt/wt wt/Mpv17 Mpv17/Mpv17 
0/44 0/103 48/48 
b. Physiological Parameters in End-Stage Disease 
wtlwt or wt1Mpv17 Mpv17/Mpv17 
Serum 
BUN (mg/dl) 22 ± 3.9 30 ± 12.5 
Creatinine (mg/dl) 0.32 ± 0.04 0.89 ± 0.19 
Cholesterol (mg/dl) 110 ± 15 424 ± 130 
Albumin (g/dl) · 3.5 ± 0.21 2.33 ± 0.34 
Blood 
ABC (x 106) 9.8 ± 0.6 5.9 ± 0.8 
HCT(%) 48.8 ± 3.3 26.3 ± 5 
HGB (g/dl) 16.6 ± 1.4 8.8 ± 1.9 
Urine 
Protein (mg/dl) 30 500 
Serum, blood, and urine samples were analyzed at Tufts University 
School of Veterinary Medicine. Sampies (1 00-200 ~~~ were Iaken from 
homozygous animals at end stage when mice showed signs of pallor, 
which was between 54 days and 6 months of age. Control samples 
were taken trom age-matched heterozygous or wt animals. ln this 
group, no changes were seen over time. Serum data are means of 20 
homozygous animals and 12 animals in the control group. Blood values 
are means ot 6 animals, and urinewas analyzed in 2 animals of each 
group. Protein values of urine trom more than 20 homozygotes were 
also tested quantitatively using test strips and all showed positive sig-
nal (data not shown). BUN: blood urea nitrogen. ABC: red blood cell 
count. HCT: hematocrit. HGB: hemoglobin. 
Figure1.3 Genetics and phenotype of the Mpv17 locus (taken from Weiher et al., 
1990) 
In order to elucidate the exact nature of the renal disease, kidneys from 
diseased and control mice were examined by light and electron 
microscopy. Early stages of the disease showed glomerular lesions, 
which were first confined to a small number of glomeruli and involved 
only a portion of each affected glomerulus, but later involved more 
glomeruli and bigger segments of them. These phenotypes are known as 
focal and segmental glomerulosclerosis. The glomeruli became 
progressively obliterated by hyaline material, which consisted of 
basement membrane components such as collagen, laminin, heparan 
sulfate proteoglycan, and entrapped plasma proteins. The basement 
membrane itself, however, showed no apparent changes except for a 
slight thickening. In end-stage disease renal tubules showed microcystic 
dilatation and accumulation of hyaline material. Electron microscopic 
studies of the affected kidneys revealed degenerative changes in the 
visceral epithelial cells (podocytes). The so called foot processes ·were, 
disturbed manifested by simplification (fusion) of these processes. 
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At later disease stages vacuolisation of the epithelial cells was observed 
and some cells were detached from the basement membrane. The 
subendothelial space of capillaries contained homogeneaus electron-
dense material, reflecting the deposition of plasma derived 
macromolecules in the subendothelial space and hyaline formation, 
which finally resulted in the complete obliteration of the glomeruli 
reminiscent of global glomeruloscerosis. Throughout the course of the 
disease there were no signs of an increased cellularity or cellular 
infiltration, which would be indicative of an inflammatory process as in 
glomerular nephritic disorders. All the parameters were characteristic 
of glomeruloscerosis and nephrotic syndrome leading to renal failure, 
and the lack of involvement of other organs, suggested that the 
phenotype was primarily caused by an impaired renal function. Thus, 
the Mpv 17 mouse should be a valuable model to approach the open 
questions regarding the molecular connections between the different 
pathological findings in glomerulosclerosis. 
The recessive nature of the defect suggested that loss of an essential 
function by insertional mutagenesis caused the phenotype. In order to 
analyse the mutation at the Mpv17 locus the flanking sequences of the 
proviral insert were cloned. Therefore a genomic library using A.EMB L 
3 phage (Frischauf et al., 1983) vectors was generated from Mpv17 
mouse liver DNA. Screening with a probe comprising the MPSV long 
terminal repeat gave rise to clones representing the 3" end of the 
provirus and about 10-15 kb of flanking mouse DNA sequences. 
Subsequently, a cloned 1.5 kb sub-fragment (Hl.5) from the integration 
region was used to isolate a 16kb insert around the pre-integration site 
form a wild type mouse genomic A.-library. Using a 340 bp non-
repetitive Sau3A subfragment it was shown that this clone represented 
the viral pre-integration site by hybridizing it to DNA from wild type, 
heterozygous, and homozygous Mpv17 mice on a Southern blot. The 
Sau3A probe detected a 3 kb band in wild type mice and a 6 kb band 
representing the Mpv17 insertional allelein DNA digested with BamHI. 
This finding showed that the Sau3A fragment detected a restriction 
fragment length polymorphism (RFLP) and therefore this probe could 
serve as a useful tool for genotyping Mpv17 mice. Additional restriction 
digests made it clear that the integration of the provirus was not 
accompanied by any detectable rearrangements. The observed phenotype 
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and its recessive nature made it very likely that a gene being necessary 
for normal kidney function was affected by the retroviral insertion. 
Genes that have an important function are often found to be evolutinary 
conserved among different species due to seletion pressure. The cloned 
region representing the pre-integration site was therefore dissected into 
12 subfragments, which differed between 500 bp and 1.5 kb in size, and 
were used as probes on genomic Southern blots of DNA from different 
species. In this so called zoo blot a probe from one species representing 
a conserved sequence should give rise to one or more distinct bands on 
DNA from other species. Indeed, one of the twelve subclones, a 800 bp 
fragment, was found to be conserved and non-repetitive as it hybridised 
to a single fragment of human, cow, rabbit, and rat DNA under 
stringent hybridisation and washing conditions. It detected a 1.7 kb 
transcript in Northern analyses on RNA from different organs of wild 
type and heterozygous mice, but not on RN A from homozygous 
animals. This probe thus fulfilled the criterion for the gene whose 
expression was inactivated by the retroviral insert. The cellular 
transcript was called the Mpv 17 transcript and the gene coding for it 
was termed the Mpv 17 gene. 
Organs found positive for Mpv17 gene expression were: heart, brain, 
kidney, testis and to a lesser extent liver and spieen. This expression 
pattern could also be seen in newly bom mice and during development, 
as demonstrated in 8 day old miceandin day 16 embryos, respectively. 
The gene is transcribed in EC (F9) and ES (D3) cells, in lines derived 
from kidney epithelial cells (TMCK-1, RAG) as weil as in NIH3T3 
fibroblasts. The Mpv17 gene was found to be ubiquitously expressed 
throughout embryonie development and in adult animals, but no 
transcription could be found regardless of age or disease status in 
homozygous animals, indicating that the provirus inhibits the stable 
expression of Mpv17 RNA. This raised the question of how the lack of 
Mpv 17 expression during embryonal development and in all the organs 
in which it is normally expressed leads to the very specific kidney defect 
described above. 
Subsequently the entire Mpv17 cDNA was cloned and sequenced. A 
cDNA library created from wild type kidney RNA was screened using 
the 800 bp fragment as a probe. The resulting complete cDNA clone 
was sequenced, revealing a total sequence of 1426 nucleotides with an 
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open reading frame of 176 amino acids. The first ATG codon was 
preceeded by a nearly perfect Kozak consensus sequence (Kozak, 1987) 
suggesting that this A TG codon is indeed the start point of translation. 
The 3 ~ region of the cDNA consisted of two repetitive elements with 
several stop codons in all reading frames. They had a high homology to 
the so called B2 and B 1 mouse repeats, respectively (Krayev, 1980, 
1982). No upstream consensus poly (A) addition signal were found, 
which is either due to the fact that the Mpv17 transcript is a gene 
without such a signal or that the clones were primed in a poly (A) 
stretch, that often follows repetitive sequences (Bimstiel et al, 1985). 
When analysed with the ALOM program (Klein et al., 1985), the 
sequence of the derived 176 amino acid protein revealed two major 
hydrophobic regions, which indicated a possible membrane association 
of the supposed protein. Furthermore, there are four cysteine residues 
that could give rise to disulphide bridges and several serine and 
threonine residues, sites of potential phosphorylation, present in the 
amino acid sequence. Besides this, the sequence gave no hints of a 
possible function. A homology search revealed no significant similarity 
with any known protein sequence. 
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Aim of the presented work 
The Mpv 17 mouse strain develops glomerulosclerosis and nephrotic 
syndrome at young age. Due to recessive transmission and the specific 
kidney phenotype that closely resembles glomerulosclerosis and 
nephrotic syndrome in man, a putative human Mpv 17 gene would be a 
prime candidate gene for inherited glomerular disease such as the 
congenital nephrotic syndrome of the Finnish type (CNF). 
The Mpv 17 mouse line was created by insertional mutagenesis which 
gave rise to the loss of expression of the Mpv17 gene. The zoo-blot 
analysis (Weiher et al., 1990) indicated that the Mpv17 gene is 
conserved between different species including man. The first objective 
was therefore to isolate and analyse the putative human Mpv 17 
(hMpv17) gene. In order to try to demonstrate an involvement of the 
human Mpv17 gene in inherited glomeruloscleroses, biopsy material 
from patients suffering from such diseases could be screened for 
mutated expression of Mpv17. In addition, regardless of its involvement 
in familial human kidney disease, understanding the normal function of 
the Mpv17 gene product should give insights into the general etiology of 
glomerulosclerosis. The unravelling of the intracellular localisation and 
the cellular distribution of the Mpv 17 protein would be the first step 
towards the elucidation of this function. For this purpose I set out to 
raise antihoclies against the Mpv17 gene product. The acquired 
information on the localisation and distribution of the Mpv 17 protein 
should give indications towards further studies of its function. The 
elucidation of the cellular distribution should also unravel whether the 
Mpv 17 protein is normally present at sites in the glomerulus that are 
affected in the mutant mouse. Such a finding would make it possible that 
the lack of Mpv17 expression in the glomerulus directly gives rise to the 
defect. 
The data obtained from these experiments combined with results from 
the analysis of other animal models for kidney disease would help in the 
set-up of appropiate assays to define the function of the Mpv17 protein. 
Trying to explain how the loss of Mpv17 function leads to 
glomerulosclerosis was the subsequent step of the project. Therefore, I 
wanted to examine parameters that could be potentially controlled by the 
action of the Mpv17 gene product and could result in glomerular injury. 
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These result should contribute to the search for the final common 
biochemical pathway that leads to glomerulosclerosis. 
A final objective of this project was to show that the loss of Mpv17 
expression indeed leads to the renal disease in the mutant mice. This 
question had to be considered, because the Mpv 17 mouse strain was 
generated by random insertional mutagenesis, so it could not be ruled 
out that another gene was affected by the proviral integration. The 
transfer of a functional copy of the Mpv17 gene into the genome of 
Mpv17 mutant animals to rescue the phenotype was an approach that 
would definitively demonstrate that the lack of Mpv17 activity gives rise 
to glomerulosclerosis in mice. Therefore l set out to make a construct 
containing the Mpv17 cDNA under the control of an appropriate 
promoter ensuring expression in the kidney to generate transgenic mice 
to rescue the phenotype. 
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Chapter 2. Materials and Methods. 
Materials 
Chemicals. Chemieals were purchased from Roth (Karlsruhe), Merck 
or Sigma, unless otherwise stated. Radiochemieals were obtained from 
Amersham. Restrietion enzymes were bought from from Promega, 
Boehringer, Mannheim or United States Biochemieals (USB). 
Unlabelled nucleotides were purchased from Boehringer, Mannheim. 
Antiborlies and DNA constructs obtained from others. All 
mouse Mpv17 constructs were obtained from Dr. Hans Weiher. The 
human cDNA A-library were provided by Dr. Peter Seeburg. The 
mouse MMP-2 DNA probe was provided by Dr. Peter Angel and the 
anti-MMP-2 antibody by Dr. Matti Höyhthä. The RSV cells were 
generated by Alexander Reuter in our laboratory. 
Solutions 
lOOxDenhardts-solution: 2% bovine serum albumin (BSA), 2% 
ficoll, 2% polyvinylpyrrolidone. 
Formaldehyde-denaturing buffer for RNA: 35f.ll formaldehyd 
(37%), 1f.ll ethidiumbromide (lümg/ml), 10J.ll 20xMOPS, 100f.ll 
formamide (deionised), 54 f.ll water. 
Hybridisation solution: 6xSSC, 5xDenhardts-solution, 0.5% SDS, 
250f.lg/ml salmon sperm DNA. 
Laemmli running buffer: 25mM Tris-acetate, 192mM glycine, 0.1% 
SDS. 
SxLaemmli sample buffer: 10% SDS, 50% glycerol, 31.25mM Tris-
HCI pH 6.8, 0.005% bromophenol blue, 25% 2-mercaptoethanol. 
20xMOPS-buffer: 400mM morpholinopropanesulfonic acid (MOPS), 
100mM Na-acetate, 10mM EDTA, pH 7.0. 
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DNA loading buffer: 8% sucrose, 50mM Tris-HCl pH 8.0, 50mM 
EDTA, 5% Triton XlOO. 
SM buffer: 5.8g NaCl, 2g MgS04, 50ml 1M Tris-HCl pH 7.5, 5ml 2% 
gelatine. 
20xSSC: 3M NaCl, 0.3M Na3-citrate. 
TAE-buffer: 40mM Tris-acetate, lmM EDTA 
TE: lOmM Tris-HCl pH 8.0, lmM EDTA 
Western transfer buffer: 29g Tris-acetate, 145g glycine, 5g SDS, 1 
litre methanol ad 5 litre water. 
Bacterial Colture and Manipulation 
Media for bacterial growth. Liquid and solid bacterial media were 
made according to the recipes in Maniatis (1982), except for 2xTY 
media, which contain 16g/l Tryptone, lOg/1 yeast extract and 5g/l NaCl. 
Ingredients were made by Difco. 
Preparation of transformation-competent bacteria. F o r 
producing competent E. coli bacteria the method of Hanahan (1986) was 
used. A 1 OOml culture of 2xTY medium containing 11100 of an 
overnight culture of E. coli Kl2/DH5a was grown to an OD550 of about 
0.3, after which the bacteria were centrifuged at 1500xg at 4° C for 5 
minutes. The supematant was removed and the bacterial pellet carefully 
resuspended in lml ice-cold STB (lOOmM KCl, 45mM Mn2Cl, lOmM 
CaC12, 3mM [Co(NH3) 6]Cl3, lOmM K-MES pH 6.5, and 10% glycerol). 
After adding another lml of STB the bacteria were left on ice for 30 
minutes, before they were again centrifuged at 1500xg at 4° C for 5 
minutes. The supematant was discarded and the bacteria resuspended in 
4ml of STB. Competent bacteria were either used immediately or were 
stored in 200j..Ll aliquots at -80°. 
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Transformation of competent bacteria. 50~1 of competent 
bacteria were mixed with the DNA and stored on ice for 20 minutes 
which was followed by 3 minutes at 37° C and again 3 minutes at 0° C. 
Then the bacteria were pelleted at 3000 rpm in a microfuge, the 
. supernatant removed, resuspended in 1 00~1 2xTY with 1 OO~g/ml 
ampicillin, and subsequently plated on 1.5% Bacto-Agar, 100 ~g/ml 
ampicillin in 2xTY. 
Production of plating bacteria. A colony of E. coli LE392 was 
picked from an TY -agar plate and inoculated into 1 OOml TY which was 
supplemented with lml 20% maitose and lml 1M MgS04• After 
culturing the bacteria overnight by 37° C they were centrifuged at 
1500xg for 10 minutes and resuspended in 50ml 0.01M MgS04. 
CeH Culture And Manipulation 
Media for tissue culture. Tissue culture media were made from 
powder obtained from Gibco, and were constituted according to the 
manufacture ~ s instructions. Penicillin and streptomycin were added to 
100 units (U) and 375U, respectively. The media were sterilised by 
filtration. Trypsin was obtained from Gibco and diluted to a 0.25% 
working solution in versene (Sg/1 NaCl, 0.2g/l KCl, 1.15g/l Na2HP04, 
0.2g/l KH2P04, 0.2 g/1 EDTA, 1.5ml/l 1% phenol red). 
Tissue culture. NIH 3T3, mouse lung fibroblasts, GM 637 cells, and 
murine primary skin fibroblasts were grown in Dulbecco ~ s modified 
Eagle~ s medium supplemented with 10% fetal calf serum (FCS). Ag8 
cells were cultured in RPMI 1640 with 10% FCS and 2.5mM glutamine 
supplementation. All cells were grown in a humid atmoshpere 
containing 6% C02 at 37° C. 
Adherant cells were passaged before reaching total confluency by first 
removing the medium and washing the cells briefly with 1 ml of 0.25% 
trypsine before another 1ml of trypsinwas applied and the cells briefly 
incubated at 37° C. After being released from the surface of the culture 
dish the cells were suspended by pipetting and diluted by a factor of 3 to 
5 into new culture dishes with fresh medium. For the freezing of cells 
they were trypsinised, transferred into a 15ml plastic tube containg 
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10ml medium and centrifuged for 3 minutes at 150xg. The medium was 
aspirated and the cells resuspended in 1 ml freezing medium which 
contained the respective medium complemented with 10% 
dimethylsulfoxide (DMSO). The cell suspensions were transferred to 
special freezing tubes and stored for 2-3 days at -80° C before they were 
moved to liquid nitrogen ( -196° C), where cells can be safely stored for 
years. Thawing of cells was perforrned by quickly warming them to 37° 
C, and plpetting them into a 15ml tubc containing lüml medium. They 
were then pelleted at 150xg, resuspended, and transferred to a culture 
dish with medium. 
Preparation of primary mouse skin fibroblasts. A piece of skin 
was taken from newborn mice, 24h after birth, and placed in Dulbecco ~ 
s modified Eagle~ s medium containing 0.05% Collagenase A 
(Boehringer Mannheim). After overnight incubation at 4° C epidermal 
cell layer was carefully removed. The remaining dermis was suspended 
by pipetting in normal medium containing 10% serum and cultured 
until cells reached confluency. 
Measurement of intracellular ROS by fluorescence. Cells 
(5x105) were washed twice with PBS, trypsinized, pelleted and stained 
with Hydroethidine (Polysciences) according to the manufacturer~ s 
recommendations. Cells (10000) were analyzed using a Becton 
Dickinson FACStar with excitation and emission settings described 
elsewhere (Rothe and Valet, 1990). 
Treatment of cells with H20 2 • Cells derived from homozygous 
animals were treated with 100mM hydrogen peroxide in growth 
medium for 30 minutes, washed, and incubated in normal growth 
medium again for 2, 6, 10 hours before Poly A + RNA was prepared 
(Keyse and Tyrell, 1989). 
Nucleic Acid Methods 
Purification of DNA. DNA purification was achieved using phenol, 
phenol/chloroform, and chloroform extraction. Phenol extraction was 
performed using an equal volume of phenol containing 0.1% 
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hydroxyquinoline, and equilibrated in 10mM Tris-HCl pH 8.0, 1mM 
EDT A. An emulsion was formed by vortexing vigorously, and the 
phases were then separated by centrifugation. The aqueous layer was 
removed for further processing, avoiding any interface. Subsequently 
extractions with phenol:chloroform (1: 1) and chloroform (24 volumes 
chloroform and one volume iso-amylalcohol) were performed. 
DNA was concentrated by ethanol precipitation adding 0.1 volumes of 
3M sodium acetate pH 4.8 and 2.5 volumes of absolute ethanol. 
Glycogen was added as a carrier where appropriate. The mixture was 
frozen at -80° C for 20-30 minutes, then centrifuged at high speed for 
more than 10 minutes at 4° C. The supernatant was removed, and the 
pellet washed in 70% ethanol. After drying under vacuum, the pellet 
was resuspended in TE. 
Tail DNA isolation. Around 2cm of a mouse tail biopsy was added to 
750Jll of 50mM Tris-HCl, pH 8.0, 100mM EDTA, 100mM NaCl, 1% 
SDS, and 0.5mg/ml proteinase K in 2ml Eppendorf tubes. The tubes 
were incubated overnight at 55° C and then mixed for 5 minutes on an 
Eppendorf mixer. After this, 250J.!l 6M NaCl solution was added and 
mixed for 5 minutes, before the tubes were centrifuged at full speed in a 
microfuge. 800Jll of the supernatant, avoiding the top phase and the 
pellet, were transferred to a new tube and supplemented with 500J.!l iso-
propanol. After mixing for 2 minutes, the tubes were spun for 1 minute 
at full speed in a microfuge. The supernatant was then carefully 
removed and the pellet washed with 1.5ml 70% ethanol. The pellets 
were briefly dried and resuspended in 500J.!l TE. 50J.!l were used for 
restriction digests in a total volume of 1 OOJ.!l. 
Plasmid Minipreparations. For the production of small scale 
plasmid DNA the method of Bimboim and Doly (1979) was used. 1.5ml 
of an overnight culture of bacteria were transferred to a 1.5ml 
Eppendorf tube and centrifuged for 5 minutes at 1500xg. The bacterial 
pellet was resuspended in 100Jll Iysozyme solution (50mM glucose, 
10mM EDTA, 25mM Tris pH 8.0, Iysozyme 2mg/ml) and left on ice for 
2 minutes before 200J.!l 0.2M NaOH with 1% SDS were added. After 
vortexing 300J.!l of 3M Na-acetate pH 4.8 solution were added. This was 
followed by a 5 minutes incubation on ice and a centrifugation at 4 ° C 
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and lOOOOxg for 10 minutes. After the centrifugation the supernatant 
was carefully removed and transferred to a new tube. The plasmid DNA 
was then precipitated with 1ml ethanol by leaving the solution for 30 
minutes at -20° C. Subsequently the DNA was pelleted by centrifugation 
at 4° C and 10000xg for 10 minutes and the DNA then resuspended in 
100~1 50mM Tris, 100mM Na-acetate pH 4.8. The DNA was 
precipitated for a second time by adding 50~1 of ethanol, an incubation 
at -20° C for 20 minutcs, and a centrifugation using the same conditions 
as above. The DNA was then resuspended in 50~1 TE. 
Plasmid Maxipreparation. A 200ml overnight bacterial culture was 
centrifuged at 4000xg for 10 minutes, resuspended in 1 Oml 50mM 
glucose, 10mM EDTA, 25mM Tris pH 8.0, Iysozyme 2mg/ml and left 
on ice for 5 minutes. Subsequently 20ml 0.2M NaOH 1% SDS were 
slowly added before the solutionwas supplemented with 15ml 3M Na-
acetate pH 4.8 and incubated on ice for 30 minutes. This was followed 
by a centrifugation at 16000xg for 20 minutes and the supematant was 
then mixed with 100ml ice-cold ethanol and left at -20° for at least 20 
minutes. The solution was again centrifuged using the same conditions as 
above, the resulting pellet resuspended in 8ml 50mM Tris, 100mM Na-
acetate pH 4.8, and transferred to a corex-tube. The DNA was 
precipitated by the addition of 20ml ethanol, incubation for at least 10 
minutes at -20° C, and a centrifugation at 10000xg for 20 minutes. The 
DNA pellet was vaccum-dried and resuspended in 4ml 50mM Tris, 
1mM EDTA pH 8.0. The subsequent density gradient centrifugation was 
performed by adding 4.1g CsCl and 320~1 ethidium bromide (10mg/ml) 
to the 4ml DNA solution, which was then transferred to a sealable 
VTi65 (Beckmann) tube. The first centrifugation was performed 
overnight at 20° C and 55000rpm in a VTi65 rotor. The plasmid 
(lower) band was removed with a 1 ml syringe and transferred to a new 
centrifugation tube wich was prepared with 4.1g CsCl dissolved in 4ml 
50mM Tris pH 8.0, 1mM EDTA. The second centrifugation was 
performed at 55000rpm at 20° C for 6h. The plasmid band was 
harvested (lml), diluted in 2ml water, and the remaining ethidium 
bromide extracted 3 times with butanol. After that the DNA was 
precipitated by adding 6ml ethanol and incubation at -20° C overnight. 
The DNA was concentrated by centrifugation at 10000xg for 20 
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minutes. The sediment was then washed with 80% ethanol, dried and 
resuspended in 300!-ll TE buffer. 
Bacteriophage minipreparation. One plaque was placed overnight 
in lml SM bufferat 4° C. On the next day 100!-ll of the phage eluatewas 
added to 50ml TY, 0.1ml of plating bacteria, and 100!-ll of Mg/Ca 
solution (10mM MgC12, 10mM CaC12). This was incubated while slowly 
shaking at 37° C for 7h. After that 2 drops of CHC13 were added and the 
suspension centrifuged at 4° C for 15 minutes at 4000xg. The 
concentrations of NaCl and PEG 4000 in the supernatant were adjusted 
to 2M and 40mM, respectively, and slowly stirred for 6h at 4° C. 
Subsequently, the suspensionwas centrifuged for 20 minutes at 4° C and 
6000xg. The supernatant was dicarded and the pellet resuspended in 
0.6ml SM buffer. 2.5!-lL DNase I (lümg/ml) were added and the 
solution incubated for 1h at 37° C. Then 2!-ll of DEPC as weil as 1.2ml 
1M Tris pH 8.5, 1% SDS, 0.1M EDTA were pipetted to the solution and 
incubated at 70° C for 5 minutes. Subsequently 0.6ml 5M potassium 
acetate were added and the solution put on ice for 30 minutes, after 
which it was centrifuged for 5 minutes at 4° C and 10000xg. 
The phage DNA in the supernatant was precipitated with 2ml iso-
propanol and centrifuged at 1 OOOOxg. The pellet was resuspended in 
500!-ll TE buffer. Two phenol extractions and one with chloroform after 
which the DNA was precipitated with ethanol for a second time 
completed the procedure. 
Bacteriophage Maxipreparation. A 50ml culture was set up 
containing 50 ml TY medium, 0.1ml plating bacteria, 0.1ml Mg/Ca 
solution (lOmM MgC12, 10mM CaC12), and 0.1 ml phage eluate. The 
culture was incubated ovemight at 37° C. On the next morning 1 or 2 
drops chloroform were added and the lysate centrifuged at 4° C and 
4000xg for 15 minutes. 1ml of the supernatant was pipetted into 1 litre 
TY medium, 1 Oml MgCa solution, and 1 Oml plating bacteria. This was 
cultured overnight at 37° C. After that 2ml of chloroform were added 
as weil as 60g NaCl, and the solutionwas centrifuged for 20 minutes at 
4 ° C and 6000xg. The supernatant was supplemented with 7 5 g/1 PEG 
4000 and stirred for 4-6h in the cold room. Subsequently, the 
suspensionwas spun at 10000xg and 4° C for 20 minutes. The pellet was 
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resuspended in 20ml SM buffer and again centrifuged for 10 minutes at 
1 OOOOxg and 4 ° C. The supernatant was transferred to a 50ml plastic 
tube, the pellet washed twice with 5ml SM buffer, and the supematants 
were combined and supplemented with DNase I to reach an end 
concentration of 10~g/ml. The solutionwas incubated for 1h at 37° C. 
This was followed by a centrifugation for 2h at 30000rpm in a 
Beckmann Ti60 rotor. The pellet was resuspended in 5ml SM buffer to 
which 0.675g/ml CsCl were addcd and then centrifuged in a Beckmann 
Ti50 rotor for 24h at 35000rpm and 15° C. The resulting phage band 
was removed using a 1ml syringe and dialysed for 1h against 50mM 
Tris pH 8.0, 10mM MgC12, 10mM NaCl. Subsequently, the dialysatewas 
transferred to a 10ml tube and supplemented with EDTA ad 20mM, 
proteinase K ad 50~g/ml, and SDS ad 0.5%, and incubated at 65° C for 
1h. After a phenol and chloroform extraction the phage DNA was 
ethanol-precipitated and finally resuspended in TE buffer. 
Preparation and analysis of Poly A + RNA from tissue culture 
cells. Poly A+ RNA was isolated from five 140mm plates, which were 
grown to 90% confluency. Cells were lysed in 1 OOmM N aCl, 20mM 
Tris-HCl, pH 7.4, 10mM EDTA, 0.1% SDS, and proteinase K 
(300~g/ml). The lysate was incubated ovemight with oligo(dT)-ceilulose 
type VII (Pharmacia). After several washing steps with 400mM NaCl, 
20mM Tris pH 7.4, 10mM EDTA, 0.2% SDS and 100mM NaCl, 20mM 
Tris pH 7.4, lOmM EDTA, 0.2% SDS , RNA was eluted with, diethyl 
pyrocarbonate (DEPC) treated, water and ethanol precipitated. 
Subsequently, the RNA pellet was purified with phenol and chloroform 
and again precipitated. 5~g of poly A+ RNA were loaded on a 1% 
agarose gel supplemented with 2.2% formaldehyd, which was run in 
MOPS buffer. The RNA was transferred to a nylon membrane (Hybond 
N, Amersham), which was prehybridized in 6xSSC, 0.5% SDS, 1% 
Ficoll, 1% polyvinylpyrrolidone, 1% BSA, and 250~g/ml denatured 
salmon sperm DNA for 2h at 65° C. The radioactively labelled probe 
(Feinberg and Vogelstein, 1983) was added and incubated ovemight at 
650C. The filter was washed 15 minutes with 2x SSC, 1% SDS and 
twice for 15 minutes in 0.1xSSC, o.5% SDS. All washing steps were 
performed at 650C in a rocking water bath. 
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Quantification of nudeic acid. The amount and purity of nucleic 
acids was estimated from the O.D. readings at 260 nm and 280 nm as 
described in Maniatis et al. (1982). 
Restrietion enzyme digestions. Restrietion enzyme digests were 
performed with commercially available endonucleases in accordance 
with the supplier" s directions. 
Agarose gel electrophoresis. Horizontal agarose gels were used for 
the Separation of DNA molecules as weil as for the size-estimation of 
DNA fragments. The normal concentration,of agarosewas 1%. Agarose 
was dissolved in T AE buffer by heating in a microwave oven. After the 
solution had been cooled down to 60° C ethidium bromide was added to 
a final concentration of 0.5Jlg/ml. The respective DNA samples were 
supplemented with 1/5 of their volume of the 5x DNA sample buffer 
before loading. T AE was used as running buffer. The separation was 
performed at a field strength of about 7V /cm. The DNA fragments in 
the gel were detected on a screen with UV light of 320nm. 
Southern blotting. Hybond N+ filters were used to blot DNA agarose 
gels as described in Maniatis et al. (1982). The transfer was usually 
performed overnight in 0.4M NaOH, after which the filterwas briefly 
washed in 2xSSC. Then the filter was either used directly in a 
hybridisation experiment or stored air-sealed at 4 ° C. Hybridisation of 
the blotted DNA to radioactively Iabelied DNA probes (Feinberg and 
Vogelstein, 1983) was usually performed at 65° C over night, after 
which the filters were stringently washed for 15 minutes in 2xSSC, 1% 
SDS, and then for 2h in 0.1xSSC, 0.5%SDS changing the washing 
solution once. 
Radiolabelied probes. DNA probes were made by the random 
priming method (Feinberg and Vogelstein, 1983) using templates 
purified by electroelution from an agarose gel fragment, and alpha-32P-
dCTP at 3000 Ci/mmol (Amersham). 
Subcloning and ligations. Vectors cut with a single restnctwn 
enzyme were treated with calf intestine alkaHne phosphatase purchased 
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from Boehringer according to the manufacture~ s recommendations. All 
vectors were isolated from agarose gels by electroelution before use. 
Ligation was performed as described (Berger and Kimmel, 1987). 
Ligated DNA was used to transform competent bacteria. 
DNA Sequencing. For DNA sequencing the Sequenase-2 kit (USB) 
was used. 1.5-2~tg of the respective plasmid were denatured in 0.4M 
NaOH for 10 minutes at room tcmperature in a 1.5ml Eppendorf tube. 
The volume was then increased to 20~1 and the denatured DNA ethanol 
precipitated by adding 10% of the reaction volume of 3M Na-acetate pH 
4.8 and 2.5 volumes of ethanol. After mixing, the reaction tubes were 
left for at least 30 minutes at -80° C. The DNA was centrifuged at 4° C 
and the pellet washed with 70% ethanol and resuspended in 1~1 water. 
The DNA was supplemented with 5pmoles of the particular sequencing 
primer in 1~1, and 2~1 5x reaction buffer (200mM Tris-HCI pH 7.5, 
100mM MgCh, 250mM NaCl). The reaction was left for 2 minutes at 
65° C and then allowed to cool down to room temperature. In the 
meantime four reaction tubes labelled G, A, T, and C were prepared 
containing 2.5~1 of the respective termination solution (SO~M dGTP, 
80~M dATP, 80~M dTTP, 80~M dCTP, 50mM NaCl and 8~M of the 
according ddNTPs). These tubes were pre-incubated at 37° C while the 
labelling reaction was performed. Therefore 1 0~1 of the annealing 
reaction (plasmid DNA+primer) were added to 1~1 of 0.1M 
dithiothreitol (DTT), 2~1 labelling mix (1.5~M dGTP, 1.5~M dCTP, 
1.5~M dTTP), 0.5~1 gamma-35S-dATP (Amersham) and finally 2U in 
2~1 Sequenase Polymerase (USB). The reaction was incubated for 5 
minutes at room temperature and subsequently 3.5~1 of the labelling 
reaction was transferred to each tube containing the four different pre-
warmed termination solution. Subsequently, these reaction tubes were 
incubated for another 5 minutes at 37° C. The reaction was stopped by 
adding 4~1 stop-solution (95% formamide, 20mM EDTA, 0.05% 
bromo-phenol-blue and 0.05% xylenecyanol), and after a 3 minutes 
incubation at 75° C loaded on a 6% polyacrylamid gel containing 7M 
urea. 
Sequencing gel electrophoreses. The separation of DNA molecules 
under denaturing conditions is usually accomplished on a 6% 
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polyacrylamid with 7M urea. The glass plates were thoroughly washed 
with detergents and ethanol before one of the plates was treated with a 
repel solution for easier separation of the plates after the run. About 
30ml of the sequence stock solution were supplemented with 180~-tl 10% 
APS and 35 ~-tl TEMED and poured between the glassplates that had 
been assembled using 0.4mm spacers and were hold together by several 
clamps. Afterpolymerisation the gel was pre-run for 30 minutes before 
the samples were loaded. The electrophoretic separation of the DNA 
fragments was performed at 1400V and about 35mA. After the run the 
gel was transferred onto a 3MM paper, covered with Saran wrap and 
dried on a gel-dryer for 2h at 80° C. The gel was then exposed to a 
Kodak X-ray film ovemight at room temperature. 
Reverse TranscriptasewPCR (RT-PCR). Total RNA was prepared 
from mouse kidneys by the guanidiniumisothiocyanate method 
(Chirgwin et al., 1979) and was enriched for polyadenylated RNA. 100 
ng of each polyA+ RNA were then used as a template to synthesise 
Mpv17 cDNA in 50mM KCl, 10mM Tris-HCl pH 8.3, 5mM MgCh, 
1mM of each dNTP (Boehringer, Mannheim), 10 units of RNase 
inhibitor (USB), 2.5 ~-tM of oligo d(T) primer (Boehringer, Mannheim), 
2.5U of avian myeloblastosis virus reverse transcriptase (AMV -RT, 
Promega) and filled up to 20~-tl with water. The samples were incubated 
for 20 minutes at 42° C and subsequently denatured at 95° C for 5 
minutes. For the PCR reaction the MgCh concentration was adjusted to 
2mM, and the final reaction volume was scaled up from 20~-tl to 1 00~-tl. 
In addition, the samples were supplemented with Mpv 17 specific 
primers from the human cDNA to a final concentration of 0.15~-tM and 
2.5U of Taq polymerase (Amersham) were added. The sequences of the 
primers used are: 
1s: 5"GAATTCGAGGCTCGGCGCTCAGGAAGC3" and 
4r: 5 "GAATTCAAACGATGGAGTGAGGCAGGC3" 
representing nucleotide pos. 9-29 (ls) and 582-561 (4r), respectively. 
After 35 cycles 20~-tl of each sample were analysed on a 1% agarose gel. 
The observed size for correct cDNA expressionwas as expected 585bp. 
In the RT negative controls the identical procedure was carried out 
omitting the reverse transcriptase enzyme. 
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Library screening. The human cDNA lvgtlü library was obtained 
from Peter Seeburg, and the genomic library from human placenta 
cloned in A Fixll was purchased from Stratagene. The libraries were 
titred and propagated on the E. coli strain LE 397 on LB plates. 
Screening and plaque purification was performed according to Berger 
and Kimmel (1987), using hybridisation buffer containing 50% 
formamide, 1M NaCl, 10% dextran sulphate and lOOJ.!g/ml sheared, 
denatured salrnon spenn DNA, at 42° C for 16h. Low stringency washes 
were performed at 45° C in 2xSSPE, 0.5% SDS, with four changes over 
two hours (20xSSPE contains 174g/l NaCl, 27.6g/l NaH2P04 and 7.4g/l 
EDTA at pH 7.4). High stringency washes were performed at 65° C, 
with one half hour wash in 2xSSPE, 0.5% SDS, then three further half 
hour washes in 0.2xSSPE, 0.1% SDS. 
Protein Methods 
SDS-PAGE. Proteins were separated on the basis of size using the 
method of Laemmli (1970). Protein samples were boiled for five 
minutes in SDS sample buffer containing 5% ß-mercaptoethanol for 
reducing sample buffer. The resolving gel contained 12.5% acrylamide, 
unless otherwise stated. Sampies were run at 20mA into the stacking gel 
and then at 40mA during the day. Gels which were Coomassie-stained 
were incubated in 0.25% Coomassie Brilliant Blue in 10% acetic acid, 
10% methanol for 1-24h. Gels were destained in 10% acetic acid, 10% 
methanol for 24h or more. 
Production of fusion proteins in bacteria. E. coli cells 
harbouring the trpE-Mpv17 plasmid were cultured in M9 medium 
supplemented with 1% casamino acids and lÜJ.!g/ml L-tryptophan 
ovemight at 37° C. The cells were diluted 1/100 into M9 supplemented 
with 1% casamino acids. Pilot studies used lüml cultures; large scale 
production used llitre cultures. Indole acetic acidwas added to a final 
concentration of lJ.!g/ml when the culture reached an OD of 0.5 at 
600nm. Cells were harvested and inclusion bodies isolated by a 
modification of the method of Klein et al. (1981). Proteins were 
dissolved in Laemmli-sample buffer and run on a preparative SDS-
p AGE. The protein was cut out and purified using an electroelution 
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device (Schleicher & Schnell) in 25mM Tris, 192mM glycine, 0.025% 
SDS. 
The human Mpv17 cDNA was cloned into the pGex 3X vector and the 
Glutathion-S-transferase (GST)-Mpv17 fusion protein expressed in E. 
coli according to Smith and Johnson (1988). The fusion protein was, 
however, purified as described above. The purity of both proteins was 
checked on an analytical SDS-PAGE and the protein solutions stored at -
20° c. 
Immunological Methods 
Generation of antibodies. For the production of monoclonal 
antibodies two Balb/c mice were injected intraperitoneally with lOOJ.!g 
of the GST-Mpv17 fusion protein suspended in complete Freund" s 
adjuvant. Three further injections with 50J.!g of the same antigen in 
incomplete Freund" s adjuvant were given intraperitoneally at three-
week intervals. Test bleeds were used in an ELISA assay and the mouse 
showing the best immune response received three intravenous injections 
of 50J.!g of purified GST-Mpv17 diluted in PBS. Three days later the 
spieen was removed from this animal and spleenocytes were fused with 
Ag8 myeloma cells using the 30% PEG/spinning method as described in 
Harlow and Lane (1988). Hybridomas were screened for specific 
antibody production by ELISA, using glutathione-S-transferase (GST) 
and the GST -Mpv 17 fusion protein on separate plates as targets. 
Hybridomas recognising only the fusion protein were grown into small 
cultures and one part of each clone frozen in liquid nitrogen while the 
other part was subcloned by limiting dilution until all wells containing 
single colanies were positive for specific antibody production. Positive 
clones were grown in large scale cultures and the supematants collected. 
They were used for the production of affinity-purified antibodies. The 
monoclonal antihoclies were isotyped by ELISA using a kit obtained 
from Biorad. 
This MAb 3D8 was purified using an anti-mouse IgM affinity column 
(Sigma), while the 6F5 and 5D2 were purified using a protein A column 
(Pharmacia). 
The rabbits were immunized according to standard protocols described 
elsewhere (Harlow and Lane, 1988) and the pre-immune sera and 
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antisera were purified via a Protein A sepharose column (Pharmacia). 
The affinity purifications were performed according to the 
manufacturers" recommendations. 
ELISA assays. ELISAs using peptides or fusion proteins as 
immobilised targets for antibody screening were performed as described 
in Harlow and Lane (1988), using secondary antibodies coupled to 
horseradish peroxidase (Dako), and 2, 2"-azinodi-[3-cthyl-benzthiazolin-
sulfonate(6)] (ABTS) as the colour reaction substrate. ELISA plates 
were purchased from Dynatech. 
Western blot analysis. Total protein extracts were prepared from 
tissue culture cells grown on 1 OOmm plates by pouring off the medium 
and washing twice with PBS. Cells were scraped off and were spun 
down in 1.5ml sample tubes. The cell pellet was resuspended in 
Laemmli loading buffer without dye, heated to 95° C for 5 minutes and 
subsequently sonified for 10 seconds. Protein concentrations were 
estimated by a mini -Bradford from Biorad. 100Jlg of total protein were 
electrophoresed on a 12.5% SDS-PAGE and transferred to an 
Immobilon-P membrane (Millipore) using a semi-dry electroblotting 
apparatus (Biorad). The filterwas blocked in 5% non-fat dried miik in 
TBS (25mM Tris pH 8.1, 144mM NaCl) containing 0.3% Tween 20 for 
lh and incubated with the polyclonal rabbit anti-Mpv17 serum and pre-
immune serum, respectively. The filter was then treated with 
horseradish peroxidase-conjugated anti-rabbit Ig (Amersham) and 
signals were detected using the ECL system (Amersham). Altematively 
the Western blot was probed with the monclonal antibodies under the 
same conditions. The 6F5 and 5D2 were detected by an anti-mouse Ig 
conjugated to horseradish peroxidase (Amersham), while the 3D8 was 
detected by a secondary anti-mouse IgM antibody conjugated to 
horseradish peroxidase (Sigma). 
Immunofluorescence microscopy. Cells were grown on glass cover 
slips for two days, after which the medium was removed and the cells 
were washed in PBS before they were fixed with freshly prepared 4% 
para-formaldehyde for 15 minutes. After washing with PBS cells were 
permeabilized using 0.2% TritonX-100 for 10 minutes before the cover 
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slips were rinsed with PBS. Primary antibodies were applied in 10% 
FCS in PBS and were incubated ovemight at room temperature. 
The Mpv 17 gene product and catalase were visualized using the 
following antibodies: MAb 3D8, rabbit anti-Mpv17-ASI and sheep anti-
bovine catalase (Binding Site). The primary antibodies were decorated 
with TRITC-conjugated goat anti-mouse (Jackson), TRITC-conjugated 
goat anti-rabbit and FITC-conjugated donkey anti-sheep secondary 
antibodies, which were incubated for 30 minutes at 37° C in PBS 
containing 10% FCS. After each incubation the cells were washed 
extensively in PBS. The cover slips were mounted on glass slides using 
Dako Glycergel and the fluorescent staining pattem was viewed in a 
fluorescence microscope (model Zeiss Axioskop). Images were recorded 
on Kodak Ektachrome Panther P1600x film. 
Immunohistochemistry. Prozen sections of kidneys were washed in 
PBS for 10 minutes, after which blocking was performed with normal 
serum from the species the secondary antibody was raised in. Then the 
diluted primary antibody was applied onto the section and incubated at 
4° C in a wet chamber overnight or 1-2h at room temperature. Then the 
sections were again washed in PBS for 10 minutes, before the secondary 
antibody was applied and incubated for 30 minutes in the wet chamber 
at room temperature. After washing for 10 minutes in PBS again, the 
sections were incubated for 30 minutes at room temperature with the 
horseradish peroxidase-anti-peroxidase (PAP) complex. Subsequently 
the sections were again washed in PBS and then treated with the freshly 
prepared and filtered substrate solution containing 3-amino-9-
ethylcarbacole (AEC) in dimethylformamide, 50mM acetate buffer pH 
4.9, and 0.03% H20 2 for 10 minutes. Finally the sections were rinsed 
with water, dried, and then mounted in a water based mounting-
solution. 
Alternatively an alkaHne phosphatase anti-alkaline-phosphatase 
(AP AAP) complex was used to detect the primary antibody. The 
blocking step can be omitted from this protocol, as the primary and 
secondary antibodies are diluted in normal serum. The substrate solution 
for the APAAP complex contained naphtole-AS-MX-phosphate (Sigma) 
in dimethylformamide, 0.1M Tris buffer pH 8.2, Levamisole for 
blocking of endogenous alkaline phosphatase activity, and Fast Red TR 
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(Sigma). This was incubated for 15 minutes at room temperature and 
then rinsed with water. The mounting solution was water based. 
Counterstainings were performed with hematoxilin. The secondary 
antibodies, complexes, and substrate reagents were bought from Dako, 
unless otherwise stated. 
Trans2enic techniques 
Cloning of the rescue construct. The mouse MT -1 promoter was 
cut out of the vector Mthgh-Dhfr (kindly provided by Dr Erwin 
Wagner, Vienna) with Eco RI and Bam Hl. The 1.8 kb fragmentwas 
gel-purified and cloned into pBluescriptiiKS using the above mentioned 
restriction sites. From a human Mpv17 cDNA, containing intron 6 due 
to incomplete splicing, the cDNA p6/2 was released with Sac I, the 1.2 
kb fragment isolated and Iigated into the according site of the 
pBluescript already containing the MT promoter. The correct 
orientation of the cDNA was verified by several asymmetric digests. 
The MT-Mpv17 (6/2) fragmentwas then released with Bss HII from the 
pBluescript vector, purified over an agarose gel, and used for 
microinjection of mouse zygotes at a concentration of 5ng/J.Ll. 
Generation of transgenic mice and genotyping. The 3kb 
promoter/gene DNA fragment was dissolved in injection buffer (lOmM 
Tris pH 7.5, O.lmM EDTA) at a concentration of 5ng/J.Ll. The DNA 
solution was sterile filtered and injected into the pronuclei of zygotes of 
female Balb/c mice mated to male Balb/c or Mpv17 mice (the latterare 
on a CFW /Balb/c background). 
Fernales were superovulated by intra-peritoneal injections of lOU of 
pregnant mare serum (PMS, Sigma) and after 48 hours with lOU of 
human chorionic gonadotropin (HCG, Sigma). Eggs surviving 
microinjection were transferred into the oviduct of pseudopregnant 
foster mice according to Hogan et al. (1986). Miceborn were tested for 
the integration of the construct DNA by Southern blot analysis of tail 
DNA. For this purpose the DNA was digested with Sac I and hybridised 
with a human cDNA probe. The mutation of the endogenous Mpv17 
gene was monitored accordingly, whereby the tail DNA was restricted 
with Bam HI and hybridized with a genomic 350bp Sau 3A restriction 
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fragment localized close to the integration site within the Mpv 17 gene. 
Hybridisations and washes were carried out under high stringency (see 
above). 
Histological Techniques 
Histology. Kidneys from homozygous and heterozygous Mpv 17 mice 
as well as MT670 mice were fixed in 4% buffered paraformaldehyde, 
dehydrated and embedded in paraplast. Three j.lm sections were 
prepared, stained with PAS (Sigma Diagnostics). 
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Results 
Chapter 3. Cloning of the human homologue of the murine 
Mpv17 gene 
The mutant mouse strain Mpv17 carries a retroviral insert in its genome 
which inactivates the Mpv17 gene leading to the development of 
glomerulosclerosis and nephrotic syndrome at young age. Zoo blot 
analysis (Weiher et al., 1990) showed that the mouse Mpv17 cDNA 
recognizes distinct bands on genomic DNA of humans, cows, rabbits, 
and rats in Southern blots under string~nt hybridisation conditions 
arguing that the Mpv17 gene is conserved among these species (Weiher 
et al., 1993). Expression studies with several murine tissues and cell 
lines indicated a widespread expression of the Mpv 17 gene. The size of 
the mouse transcript is around 1.7kb and can be found in brain, liver, 
heart, testis, kidney, and murine celllines such as NIH 3T3. 
Given the assumed conservation of the murine and human Mpv17 
sequence, as shown by the zoo blot analysis, the gene was thought to be 
present and to have an important function in humans, too. Therefore, 
the lack of Mpv17 expression or a mutated form of it could be involved 
in human kidney disease. So far only one human genetic defect has been 
molecularly characterised that is associated with a predominant 
glomerulosclerosis phenotype. This disease is called Alport syndrome, 
and is caused by mutations in the various a-chains of the collagen type 
IV (Hostikka et al., 1990). For other glomerular diseases, based on 
family clustering, a genetic cause, for example in CNF (Hallmann et al., 
1956), is strongly suspected. The latter disease presumably originated as 
a single mutation event a few centuries ago and the carrier frequency is 
estimated to be 1 in 200 among the Finnish population. The human 
Mpv 17 gene is potentially one of the prime candidate genes for CNF or 
one of the other familial glomeruloscleroses. These familial renal 
defects could be caused by the Iack of expression or by mutation of the 
human homologue of the Mpv17 gene. Biopsy material or DNA from 
such patients therefore needed to be screened for expression or 
mutations in the proposed human Mpv17 gene in order to test for an 
association of it with any of these genetic kidney diseases. 
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All other cases of primary glomerular diseases evoking the nephrotic 
syndrome are idiopathic, i.e. of unknown etiology. However, even in 
these cases the Mpv17 gene could play a causative role in the 
development of the condition. This is because some of the idiopathic 
nephrotic syndromes might have not yet been identified as familial 
entities since they are too rare and show no geographical clustering. In 
addition, the action of Mpv 17 could be indirectly affected by substances 
controlling its expression or interacting with the gene product. Thus, 
studies on the regulation of Mpv 17 expression are important in the 
context of defining other factors leading to glomerulosclerosis. 
Cloning and analysis of the human Mpv17 cDNA 
In order to address these issues it was first necessary to study whether a 
human Mpv 17 gene does indeed exist and to which extent it is conserved 
compared to the murine gene. Hence, a A.gt10 liver cDNA library 
(kindly provided by P. Seeburg) was screened using the coding region 
of the mouse cDNA as a probe. The inserts of several phages were 
isolated, cloned into pBluescriptiiKS and sequenced. This revealed that 
the three largest inserts out of a total of eight isolates altogether had 
identical 5 _, ends and differed only in the length of their poly A tail 
which indicates the independence of these clones. As shown in Figure 
3.1 the sequence analysis revealed a striking homology between the 
mouse and the human gene. It was determined to be 92% for their 
coding regions, while the degree of homology rapidly decreases in the 
5-' and 3-' non-coding regions, as depicted in Figure 3.2. 
The comparison was performed using the 'bestfit-' and 'gap' application 
from the GCG program (Genetics Computer Group, 1991). From the 
striking degree of similarity it is assumed that the human and mouse 
gene fulfil the same function and all further experiments were therefore 
performed with the human cDNA if not otherwise stated. The high 
homology also strongly suggests an important role of the Mpv 17 protein 
in normal human kidney function, stressing its possible role in inherited 
kidney disease. 
Taking the first ATG which is preceded by a nearly perfect Kozak 
consensus sequence (Kozak, 1987) as the start point of the open reading 
frame, both the human and mouse nucleotide sequence have the capacity 
to code for a 176 amino acid protein. Furthermore, S 1 analysis (Reuter, 
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1993) suggested that the Y end of the cDNA is indeed the start point of 
transcription. The deduced amino acid sequence of the human and 
murine cDNA, however, gave no hints of a possible function of the 
Mpv 17 protein, and no functional units, could be identified, apart from 
two to four possible membrane spanning regions (see chapter 4). 
Cloning of the genomic locus of the human Mpv17 gene 
Digests of genomic DNA with the restriction enzymes EcoRI, BamHI, 
Bglii and Pstl, which were Southern blotted and probed with the 
human Mpv17 cDNA showed a very simple pattern of fragments 
(Figure 3.3a), indicating that the coding region is encompassed in only a 
small stretch of about 15 kb. The isolation of the cDNA made it also 
possible to clone this genomic region of the human Mpv 17 gene. A 
human placenta A.FIXII genomic library (Stratagene) was screened with 
the isolated human Mpv17 cDNA resulting in two A.-clones named A-3 
and A-5 (Figure 3.3). The two clones A.3 and A.5 contain fragments of 
15kb and 1 Okb in length, respectively. In order to test whether these 
clones indeed represent the Mpv17 genomic region, A.3 and A.5 DNA as 
weil as human genomic DNA was subjected to endonuclease digests 
using four different restriction enzymes. lt emerged from these 
restriction analyses that the two A, clones represent the Mpv 17 genomic 
locus, since the two clones and human genomic DNA give rise to 
identical bands after digestion with the same restriction enzyme and 
detection with the human Mpv17 cDNA probe (Figure 3.4a). These 
findings are also consistent with the notion that the Mpv 17 gene is a 
single copy gene in humans and no pseudogenes are present in the 
genome. In addition, it became clear that the two A, clones were 
overlapping (Figure 3.3), demonstrated by DNA fragments of the same 
size, such as the 5.6 kb BamHI fragment, that light up in the Southern 
analysis (Figure 3.4b). 
In summary the cloning and analysis of the human homologue of the 
mouse glomerulosclerosis gene Mpv17 revealed that both genes are 
almost identical. It suggests that the human gene product is 
correspondingly important for the normal function of the human 
kidney. The identification and analysis of two A, clones representing the 
genomic region demonstrated that the human Mpv 17 is a single gene, 
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and ailowed further studies to investigate the role of Mpv 17 in human 
kidney disease. 
The role of Mpv17 in inherited human glomerulosclerosis 
The human Mpv17 cDNA clone as weil as the genomic clones and 
subclones were used to test whether Mpv17 is involved in CNF. The 
condition resembles the Mpv17 phenotype by its autosomal recessive 
inheritance, early detectable proteinuria and similar histopathological 
findings such as tubular dilations and the fusion of the foot processes of 
the visceral epithelial ceils (Norio and Rapola, 1989). Among the 
various diseases responsible for a congenital or infantile nephrotic 
syndrome, CNF is the best known. Besides diffuse mesangial sclerosis 
(DMS) which is genetically less weil characterised, it is the only familial 
nephrotic syndrome, and a causal gene defect has not been identified yet 
(Habib et al., 1993). Therefore, the potential involvement of the human 
Mpv 17 gene was examined. 
Expression of Mpv17 RNA in kidneys from a CNF patient was found 
unchanged when compared to a healthy person. No point mutations 
could be found in cDNA from nephrectomy material from that patient 
(Hans Weiher, personal communication), and restriction fragment 
length polymorphism (RPLP) analyses was unable to detect a linkeage 
between the human Mpv17 gene and CNF (Karl Tryggvason, personal 
communication). In the meantime the CNF locus has been mapped to the 
long arm of human chromosome 19 thereby excluding eight genes 
coding for basement membrane components (Kestila et al., 1994b) as 
weil as Pax-2 (Kestila et al., 1994c) that has been shown in a transgenic 
mouse to be associated with glomerulosclerosis (Dressler et al., 1993). 
However, the human Mpv17 was assigned to chromosome 2p21-23 
(Karasawa et al., 1993) by fluorescent-in-situ-hybridisation (FISH)-
analysis using the A-5 subclone pBS 5.6 (Figure 3.5). This is further 
evidence that the Mpv17 gene is not involved in the development of 
Finnish nephropathy. The murine Mpv 17 gene was assigned to 
chromosome 5 using somatic cell hybrid panels (Karasawa et al., 1993) 
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Expression of the human Mpv17 gene. 
The mouse Mpv17 gene was shown to be transcribed in a number of 
murine tissues and several cells of rodent origin such as NIH 3T3, F9, 
D3, TMCK-1, and RAG cells, the latter two being derived from kidney 
epithelium (Weiher et al., 1990). lt was also shown that the Mpv17 gene 
is expressed in human kidneys (Weiher, 1993). We found Mpv17 
transcription in different human cells as depicted for GM637 cells in 
Figure 3.6. This figure also shows that the human Mpv17 cDNA probe 
detects the mouse transcript in NIH 3T3 cells while fibroblasts derived 
from Mpv17 homozygotes are negative, as expected, for expression of 
Mpv17. Other human cells that were positive for Mpv17 transcription 
include several primary fibroblasts and 293 cells (data not shown). 
For the analysis of the Mpv 17 protein expression the generation of 
antibodies against the Mpv 17 gene product was required. 
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1 GTGGGAGGGA GGCTCGGCGC TCAGGAAGCA TGGCACTCTG GCGGGCATAC 
51 CAGCGGGCCC TGGCCGCTCA CCCGTGGAAA GTACAGGTCC TGACAGCTGG 
101 GTCCC'I'GA'I'G GGCCTGGGTG ACATTATCTC ACAGCAGCTG GTGGAGAGGC 
151 GGGGTCTGCA GGAACACCAG AGAGGCCGGA CTCTGACCAT GGTGTCCCTG 
201 GGCTGTGGCT TTGTGGGCCC TGTGGTAGGA GGCTGGTACA AGGTTTTGGA 
251 TCGGTTCATC CCTGGCACCA CCAAAGTGGA TGCACTGAAG AAGATGTTGT 
301 TGGATCAGGG GGGCTTTGCC CCGTGTTTTC TAGGCTGCTT TCTCCCACTG 
351 GTAGGGGCAC TTAATGGACT GTCAGCCCAG GACAACTGGG CCAAACTACA 
401 GCGGGATTAT CCTGATGCCC TTATCACCAA CTACTATCTA TGGCCTGCTG 
451 TGCAGTTAGC CAACTTCTAC CTGGTCCCCC TTCATTACAG GTTGGCCGTT 
501 GTCC.AJ.\TGTG TTGCTGTTAT CTGGAACTCC TACCTGTCCT GGAAGGCAC.A 
551 TCGGCTCT.A.A GCCTGCCTCA CTCCATCGTT TCCACCTTGC AGTG.ATGC.AG 
601 CTTGACCCTG G.A.ACGGTC.AG .AC.A.ACCTCCT CAAAGTGGGC AT.ACC.AGTTT 
651 CC.ACGGGGTT GGGTTGCCGG TC.AG.AGCTT.A AG.AGGACTAG C.ACCTGCA.AT 
701 GCCCTCTTCA CTCTAAATGT .ACACTGACTG CTTTAGAGCC CTTGATAATA 
751 GTCTTATTCC CACC.AC.ATAC TAGGCACTCC ATAAAT.ATCT GTTGAACCTT 
801 C.ATGACCTTA TCAACTTTAC .ACCCATATCC AGC.AAATGCC ACTC.ATCCCC 
851 ACTCTTCAT.A GAC.ACATTTG TTACTCTAAC CCTGCCT.AGG CTTCTTGT.AG 
901 CTCCAGCTCT TTAG.AGACTC CGGGAACCCT TTATATGGTG CCTCAGT.AAA 
951 TATGTTATTA A.AT.ATGTAAT CCGG 
Figure 3.1 Nucleotide sequence of the human Mpv17 cDNA sequence. 
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1 ................... GTGGGAGGGAGGCTCGGCC;CTCAGGAJ\GCAT 31 
I! : ! ! ! II i 1111! i!;! I 
1 CCCAGTCACCTGAGAGJl.AGGTTCTGCGCAGAGCTGGCACTCAGGGAGCJ\T SO 
32 GGCACTCTGGCGGGCATACCAGCGGGCCCTGGCCGCTCACCCGTGGAAAG 81 
111111111111 III! I i III I 11111111 II i i II i I: 11111 
51 GGCACTCTGGCGAGCATACCAGAGAGCCCTGGCAGCACATCCGTGGAAAG 100 
82 TACAGGTCCTGACAGCTGGGTCCCTGATGGGCCTGGGTGACATTATCTCA 131 
I 11111 11111111111 II 11111111 i I 11111111 111111 
101 TCCAGGTTCTGACAGCTGGATCACTGATGGGCGTAGGTGACATGATCTCA 150 
132 CAGCAGCTGGTGGAGAGGCGGGGTCTGCAGGAACACCAGAGAGGCCGGAC 181 
11111111111111111111111111 111 11111111 111111 II 
151 CAGCAGCTGGTGGAGAGGCGGGGTCTCCAGCAACACCAGGCAGGCCGCAC 200 
182 TCTGACCATGGTGTCCCTGGGCTGTGGCTTTGTGGGCCCTGTGGTAGGAG 231 
111111111111 11111111111 i III i i II i II i i II i II ! i i i II 
201 TCTGACCATGGTATCCCTGGGCTGTGGCTTTGTGGGCCCTGTCGTCGGAG 250 
232 GCTGGTACAAGGTTTTGGATCGGTTCATCCCTGGCACCACCAAAGTGGAT 281 
1111111111 II II i II I i I ! I! i I I! II i I i I II I II I i 
2 51 GCTGGTACAAAGTTTTAGACCACTTAATCCCGGGCACCACGAAGGTGCAT 3 C• 0 
282 GCACTGAAGAAGATGTTGTTGGATCAGGGGGGCTTTGCCCCGTGTTTTCT 331 
11111111111111111111 11111111111111111111 11111 II 
301 GCACTGAAGAAGATGTTGTTAGATCAGGGGGGCTTTGCCCCATGTTTCCT 350 
332 AGGCTGCTTTCTCCCACTGGTAGGGGCACTTAATGGACTGTCAGCCCAGG 381 
ll\lllllllll\lllll\11 111 111 111111 111111111111 
351 AGGCTGCTTTCTCCCACTGGTCGGGATACTCAATGGAATGTCAGCCCAGG 400 
382 ACAACTGGGCCAAACTACAGCGGGATTATCCTGATGCCCTTATCACCAAC 431 
1111 11111111111 1111111 II 11111111111 11111\lll 
401 ACAATTGGGCCAAACTGAAGCGGGACTACCCTGATGCCCTCATCACCAAC 450 
432 TACTATCTATGGCCTGCTGTGCAGTTAGCCAACTTCTACCTGGTCCCCCT 481 
11111111 lllllllllllllllllllllllllllllllllllllllll 
451 TACTATCTCTGGCCTGCTGTGCAGTTAGCCAACTTCTACCTGGTCCCCCT 500 
482 TCATTACAGGTTGGCCGTTGTCCAATGTGTTGCTGTTATCTGGAACTCCT 531 
111111111111! I 11111111 111111111 II 11111111\111 
501 GCATTACAGGTTGGCTGTTGTCCAGTGTGTTGCTATTGTCTGGAACTCCT 550 
532 ACCTGTCCTGGAAGGCACATCGGCTCTAAGCCTGCCTCACTCCATCGTTT 581 
1111 llllllllllllllll I 1111111 11111 11111 1111 
551 ACCTATCCTGGAAGGCACATCAGTTCTAAGCGTGCCTTGTTCCATGGTTT 600 
582 CCACCTTGCAGTGATGCAGCTTGACCCTGGAACGGTCAGACAACCTCCTC 631 
lllllll I 1111111 I 1111111 i II\ I I II II I II II 
601 GCACCTTGTACTGATGCACCGTGACCCTGGAATGCTTGGACAGCTTCTTC 650 
632 AAAGTGGGCATACCAGTTTCCACGGGGTTGGGTTGCCGGTCAGAGCTTAA 681 
111 I II I II\ I 111 II I I 111 
651 AAACTAACCACATCAGGACTGGAGCGGTGACTCAGCTGTTAGAAGCACGG 700 
682 GAGGACTAGCACCTGCAATGCCCTCTTCACTCTAAATGTACACTGACTGC 731 
II I II I i I I II I I I 
701 ATTATCTGCTCTACAGAGGACCTAAATTTGGTTCCAAGCACCCACATCGG 750 
732 TTTAGAGCCCTTGATAATAGTCTTATTC.CCACCACATACTAGGCACTCC 780 
I I II II I ! I!! I II I I II\ 
751 GTGGCTCACAACTCCCTATGTCTCAAGCTCCAGGAGATCTGATGTTCTCT 800 
781 ATAAATATCTGTTGAACCTTCATGACCTTAT ....... CAACTTTACACC 823 
II II I II II I I I I I I I ! II II 
801 TCTGGCCTCTGAAGCACCTGCACAAACATGTATATACCCACGAATAGACA 850 
824 CATATCCAGCAAATGCCACTCATCCCCACTCTTCATAGACACATTTGTTA 873 
I I I I I I I I I I I I ! I i I II I 
851 CGCATTTGTAATTAAGCACACAATGAAATCTTTAAAAGGAAGGAGTGTGT 900 
874 CTCTAACCCTGCCTAGGCTTCTTGTAGCTCCAGCTCTTTAGAGACTCCGG 923 
I II 111 II I I I I I I 
901 CAGCTTCCATGCTATGGGGTTGCTGATCAGAATAGGGTGACCACTCTGAA 950 
924 GAACCCTTTATATGGTGCCTCAGTAAATATGTTATTAAATATGTAATCCG 973 
I I II I 11111 1111111 I I 
951 GTGGCACATTTCACTTTAACCACTAAGACATTTATAATATTGCTGTCACT 1000 
Figure 3.2 Nucleotide sequence of the human Mpv17 cDNA (top) as compared to its 
murine homologue (bottom). Both sequences can code for proteins of 176 amino acids. 
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Figure 3.3 The human Mpv17 locus cloned in two 'A phages. a: Southern blot of 
human genornic DNA. b: Southern blot of two /.., phages covering the Mpv17 region. 
The left lane contains 'A3 DNA, the right lane 'A5 DNA for each enzyme, respectively. 
Both blots were probed with the coding region ofthe human cDNA (p317-10) 
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Figure 3.4 Map of human Mpv17 genomic locus and the genomic clone !v3 and !v5. 
BamH1 (B) and EcoR1 (E) restriction sites are indicated. The sizes of the exons are 
depicted as bars. 
Figure 3.5 Mapping of the human Mpv 17 gene to 2p23-p21. 1 OOng of biotin labelled 
!v5 subclone p5.6 DNA were combined with 10mgofhuman Coq- DNA (BRL) in a 
10ml hybridisation cocktail and hybridised to human metaphase chromosomes. The 
bound probe was visualized via FITC-conjugated to avidin (see arrow). Chromosomal 
counterstaining with DAPI resulted in a Q-banding like pattem. Note that the highly 
specific FITC signals are located within 2p23-p21. Digitized images ofFITC and DAPI 
fluorescence were generated separately with the use of a CCD camera (Photometrics), 
processed and overlayed electronically. Photographs were taken from the video screen. 
(The FISH analysis was performed in Dr. Peter Lichters lab, Heidelberg) 
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Figure 3.6 Mpv17 expressioninhuman and murine fibroblasts. Poly(A)+ RNA was 
prepared from GM637 (lane 1), NIH3T3 (lane 2), and fibroblasts from Mpv17 
homozygous mice (lane 3). 4 J.Lg were loaded per lane. As a probe the human cDNA 
clone p31710 (Karasawa et al., 1993) was used. 
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Chapter 4. Mpv17 protein analysis and generation of Mpv17 
specific antibodies 
The calculated molecular mass of the 176 aa Mpv17 protein is around 
20 kD assuming that no significant post-translational modifications 
occur. The two hydrophobic regions predicted by the ALOM programm 
(Klein et al., 1985), spanning from position 94 to 114 and from 140 to 
165, are conserved to the same extent between the human and mouse 
gene as is the rest of the sequence; only four amino acids out of together 
4 7 are varied. In the first stretch encompassing 21 amino acids 
isoleueine 110 and methionine 114 in the mouse sequence are exchanged 
for an alanine and leueine residue, respectively. The second 
hydrophobic region (26 aa) long contains a switch from the murine 
isoleueine at position 163 to valine and from valine 164 to isoleueine in 
the human sequence. All four changes do not convert the hydrophobic 
character of the two stretches, thereby allowing for membrane 
association of the mouse and the human Mpv17 protein. However, both 
proteins contain conserved proline residues in their hydrophobic 
regions, which are not commonly found in typical membrane-spanning 
domains. Four cysteine residues at position 59, 99, 103, and 160 
potentially giving rise to disulfide bridges can be found in the murine as 
weil as in the human amino acid sequence. Threonine (80) and serine 
( 170) residues in both sequences have been identified as potential 
phosphorylation targets by protein kinase C, while the serines at position 
115 and the threonines at position 111 can be potentially phosphorylated 
by casein kinase II (Weiher, 1993). 
Homology to the peroxisomal membrane protein 22 
An EMBL database search revealed an interesting homology to the 
peroxisomal membrane protein (pmp) 22, that was recently cloned from 
a rat cDNA expression library and its nucleotide and deduced amino 
acid sequence established (Kaldi et al., 1993). This protein has been 
described as being a major component of rat peroxisomes (Hartl et al., 
1985; Hartl et al., 1987) and a pore-forming activity has been attributed 
to it (Van Veldhoven et al., 1987), although its precise function in the 
peroxisomal membrane remains unclear. A sequence comparison 
according to the TFASTA algorithm (Lipman and Pearson, 1985) of 
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Mpv17 with the pmp 22 protein sequence revealed 28% identical amino 
acids in a stretch of 155 overlapping amino acids and an intriguing 
overall sequence similarity of 54% (Figure 4.2). When the topology of 
the two proteins was investigated by hydropathy analysis using the 
algorithm of Kyte and Doolittle (Genetics Computer Group, 1991) the 
profiles as shown in Figure 4.3 (a, b) turned out to be quite similar. 
This points to a potential relatedness between the two proteins with 
respect to their intracellular localisation and possibly their function. In 
contrast to the ALOM programme this analysis revealed four possible 
transmembrane stretches instead of two. It has been reported that these 
membrane spanning sequences are often flanked by one or more 
charged amino acids and that the kind of charge is important for the 
orientation of the protein in the membrane (Dalbey, 1990; Hartmann et 
al., 1989). For bacterial membrane proteins it has been noted that when 
viewed from the N-terminus to the C-terminus, the transmembrane 
stretch is preceded by a positively charged residue such as Iysine and 
arginine and terminated by glutamic acid. 
According to Singer (1990) the pmp 22 protein fits the definition of a 
type Illb integral membrane protein. Type IIIb membrane proteins 
possess more than one transmembrane sequence and an NH2-terminus on 
the exterior face of the membrane. The Mpv17 protein roughly follows 
these rules, but shows a slightly different picture. Trying to 
superimpose the topological model for the pmp 22 (Kaldi et al., 1993) 
onto the Mpv 17 protein requires four membrane spanning regions as 
predicted by the Kyte and Doolittle analysis and shifting of the two 
hydrophobic stretches as predicted by the ALOM programme in order 
to better fit the hypothetical model. The existence of four membrane 
associated domains in the Mpv 17 protein would also be in better 
accordance with the Chou-Fasman analysis (Genetics Computer Group, 
1991) that is shown for the Mpv 17 protein as well as for the pmp 22 in 
in Figure 4.3 (c, d). Whether the Mpv17 protein also belongs to the 
group of type Illb membrane proteins and truly parallels the pmp 22 
membrane topology requires further studies. 
So far, no target signals have been identified for peroxisomal membrane 
proteins, while for peroxisomal matrix proteins two such signals have 
been identified (Gould et al., 1989; Swinkels et al., 1991). The Mpv17 
protein and the pmp22 Iack these signals, which is in accordance with 
55 
the hypothesis that the Mpv 17 protein, as pmp 22, is a peroxisomal 
membrane protein. Due to the lack of signal sequences, the underlying 
mechanism of peroxisomal membrane targetting is completely unknown. 
Raising antibodies against Mpv17 protein. 
In order to investigate if Mpv 17 is indeed a peroxisomal protein, as 
suggested by the sequence and topological similarities with the 
peroxisomal membrane protein 22, thc actual intracellular localisation 
of the Mpv17 protein needed to be determined. It is important to 
elucidate the intracellular localisation of a protein, since it gives first 
insights into the possible function of the protein, andin the Mpv17 case 
could reveal a new link between a peroxisomal function and kidney 
disease. 
Production of recombinant Mpv17 fusion proteins as antigens 
for immunisation. 
Antibodies were raised against two bacterially expressed recombinant 
hMpv17-fusion proteins and two peptides taken from the Mpv17 
sequence. 
One of the fusion proteins contained the 34 kD Trp E protein from 
Escherichia coli (Ausubel et al., 1984), while the second one was created 
by fusing the 27 kD glutathione-S-transferase (GST) from Schistosoma 
japonicum (Smith and Johnson et al., 1988) to the open reading frame of 
the human Mpv17 gene. The prokaryotic part was located at the N-
terminus of the resulting fusion proteins, and both contained the entire 
coding region of the human· Mpv17 gene at the C-terminus. While the 
Trp E fusion protein was already available in the lab (provided by H. 
Weiher) the construct for the GST-Mpv17 protein needed tobe cloned 
(Figure 4.4). The expression vector system pGex offers three different 
plasmids for the three possible reading frames so that at least one 
cloning strategy will always lead to in frame fusion of the Mpv17 
reading frame to the carboxyl terminus of the Schistosoma japanicum 
GST. Normally the OSTfusion proteins aresoluble in aqueous solutions 
and can then be purified from crude bacterial lysates under non-
denaturing conditions by affinity chromatography on immobilized 
glutathione. W e chose the strategy of cloning the hMpv 17 segment in 
frame with the GST sequence using the Sma I site in the cloning site of 
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the pGex 3X vector. Therefore the pBluescript vector containing the 
human Mpv17 cDNA was cut with Dde I at position 20 and 557 which 
released the entire coding region of the human Mpv17 gene. Positive 
clones were identified and the correct orientation was determined using 
asymmetric digests with Pst I at position 160 in the cDNA and position 
1340 in the pGex vector. These clones were tested for expression of the 
desired fusion protein in small-scale-cultures. For that purpose the 
respective E. coli clones were grown for two hours and then induced 
with IPTG for one hour before the bacteria were harvested, spun down, 
and directly resuspended and solublized in denaturing Laemmli sample 
buffer (see Material and Methods). An aliquot was loaded on a standard 
12.5% SDS-Polyacrylamidgel (SDS-PAGE) and the proteins visualised 
by staining with Coomassie-blue. As a control, a parallel culture of each 
clone was grown, but was not induced with IPTG and then also loaded 
on the gel. In order to check for functional induction an established 
clone harbouring the empty GST vector only was analysed in parallel. 
The result of this experiment is depicted in Figure 4.5. Several 
independent insert-positive clones of correct insert orientation were 
analysed alongside with GST vector controls. A band of 27 kD can be 
seen in lane Ci (stimulated GST control) as opposed to the uninduced 
cuiture. Of the four clones, only clone 6 resulted in a band of the 
expected size of 46 kD for the desired GST-Mpv17 fusion protein. The 
other clones tested did not produce an inducible protein for unknown 
reasons. The recombinant plasmid of clone 6 was then also tested for the 
correct reading frame by sequencing the connection of the GST 
sequence to the Mpv17 cDNA segment. This had the expected sequence, 
ensuring the production of the genuine Mpv17 polypeptide within the 
fusion protein. This clone was then grown in a large scale culture and 
was subjected to the standard purification protocol for GST fusion 
proteins (see Material and Methods). In the course of this procedure it 
tumed out that the GST-Mpv17 fusion protein was insoluble in aqueous 
solution, probably due to storage in inclusion-bodies (Smith and J ohnson 
et al., 1988), and could therefore not be purified on the glutathione 
agarose column. Several attempts to keep the GST -Mpv17 protein in 
solution, such as lowering the incubation temperature of the bacteria 
from 37° C to 28° C, decreasing the induction time from 5h to 2h, and 
finally a combination of both, were not successful. Likewise, when the 
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fusion protein was solubilised in 6M urea and then dialysed in small 
steps against decreasing concentrations of urea, the protein precipitated 
at urea concentrations below 4M. The insolubility of the GST-Mpv17 
protein could be explained by its hydrophobic regions. It should also be 
mentioned that insolubility of recombinant proteins in bacteria is seen 
occasionally in proteins not harbouring such regions (Marston et al., 
1986 and R. Vallon, personal communication). For these technical 
reasons the GST-Mpv17 proteinwas purified by conventional methods 
from the producer-cells by preparation of inclusion bodies and 
denaturation in reducing Laemmli sample buffer, followed by 
preparative SDS-PAGE. The 46 kD band of the fusion protein was 
visualized by negative staining using 4 M potassium acetate, and the 
protein was eluted from the gel slice by electro-elution. The purity of 
the isolated protein was demonstrated by analytical SDS-PAGE as 
depicted in Figure 4.6. The purified protein was recognized by a 
polyclonal antibody against the GST-domain (data not shown) indicating 
that indeed a protein containing GST had been purified. Since no other 
GST protein especially of that size was expected in the preparation it 
was reasonably safe to assume that it was the desired GST-Mpv17 fusion 
protein. The concentration of SDS in the elution buffer was too high to 
ensure a quantitative protease digestion with factor Xa at the respective 
site in the fusion protein which would cleave the Mpv17 protein from 
the GST part. Therefore the complete GST-Mpv17 proteinwas used in 
addition to the TrpE-Mpv17 product for the immunisations (see below). 
Mpv17 peptides used for immunisation 
U sing whole proteins as immunogens has the advantage that many 
different epitopes are presented to the immune system. This · should 
ensure that the resulting antihoclies are likely to recognize the respective 
protein even if denatured. An alternative is the use of peptides, which 
has the advantage that antihoclies can be prepared when the 
corresponding protein is only available in small quantities, is difficult to 
purify, or when the sequence is only partially known. Additionally, the 
region of the protein that the antibody recognizes is known from the 
peptide sequence, making it possible to target antihoclies to specific 
regions of a protein. However, the disadvantage is that one cannot be 
certain that the peptide sequence corresponds to an epitope on the intact 
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protein, perhaps generating antibodies that do not recognize the native 
or even the denatured protein. By following empirical guidelines 
according to Harlow and Lane (1988) it is nevertheless often possible to 
design peptides which will constitute an epitope. The peptides selected 
from hydrophilic regions of the human Mpv 17 sequences with the 
following sequences were designed according to these rules: 
Peptide 1: VERRGLQQHQAGRTLTMK (pos.: 38-54+K) 
Peptide II: QDNW AKLKRDYPDAL (pos.: 117-131) 
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Immunisation of rabbits with the peptides and fusion 
proteins. 
The generation of polyclonal antibodies is a relatively quick and easy 
way to obtain an antiserum that usually functions well in commonly used 
protein assays such as immunoprecipitation, Western blots, and cell 
staining. Polyclonal antibodies suffer, however, from the disadvantage 
that many of them display background signals due to the presence of 
antibodies in the serum directed against other determinants to which the 
animal has been exposed. 
Antibady /x Antigen Animal ELISA West. a-rec. West. a-ext. 
Pep. I (PC) peptidel rabbit + - -
Pep. II (PC) peptideil rabbit + - -
AS-I (PC) GST-Mpv17 rabbit + + + 
AS-II (PC) GST-Mpv17 rabbit - - -
aTrpE. (PC) T_rpE-M_pv17 rabbit + + n.a. 
5D2 (Mab) GST-Mpv17 mause + + n.a. 
6F5 (Mab) GST-Mpv17 mause + + + 
3D8 (Mab) GST-Mpv17 mause + + + 
Table 4.1 anti- Mpv 17 antibadies (PC=palyclanal antibady; Mab=manaclanal 
antibady, n.a.=nat analysed, West. a-rec=Westem an the purified recambinant protein, 
West. a-ext.=Westem an cell (3T3; GM 637) pratein extract) 
The peptides I and II coupled to the hapten Keyhole limpet 
hemacyyamin (KLH) were each injected into a rabbits following the 
protocol outlined in Harlow and Lane (1988). ELISA test of the antisera 
anti-peptide I and anti-peptide II on the respective peptides were 
positive. Repeating the test with recombinant GST-Mpv17 protein 
revealed, however, that both anti-peptide sera were not able to 
recognize epitopes on the whole denatured protein. Additional 
experiments such as Western analysis and cyto-immunofluorescence 
with these sera also gave negative results (Table 4.1). Therefore these 
antisera were not used for further analyses. 
Two rabbits were immunised with the GST-Mpv17 fusion protein. In 
addition, a rabbit was immunised with the TrpE-Mpv17 fusion protein 
according to general procedures (Harlow and Lane, 1988). From all 
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three animals pre-immune sera were taken before the first inoculation 
with antigen and designated PSI and PSII for the two rabbits that were 
injected with the GST-Mpv17 and PS-TrpE for the animal immunised 
with TrpE. 
The corresponding antisera ASI, ASII, and anti-TrpE-Mpv17 were 
tested in ELISA and Westernanalysis against the isolated recombinant 
proteins and against whole cell p~otein extract (Table 4.1). Anti-TrpE-
Mpv17 gave a positive response in an ELISA assay against thc TrpE-
Mpv 17 as weil as against the GST-Mpv 17 protein, further indicating 
that the Mpv 17 portion of the fusion protein was recognized. Additional 
analyses, however, such as Western blots and immunoprecipitations of 
protein extracts from cells known to express Mpv17 mRNA using the 
anti-TrpE-Mpv17 serum were unsuccessful. On the other hand the 
antisera ASI responded positively in the ELISA test and detected an 
additional band, in comparison to the preimmune-serum (Figure 4.7). 
This band had the expected size of the Mpv17 gene product of about 20 
kD in whole-cell protein extracts from mouse and human fibroblasts, 
expressing Mpv17 RNA (Figure 3.6) in an immuno-blot experiment. 
This result indicated that ASI does specifically recognize the Mpv17 
protein as a band of 20 kD, that is not detected by the respective 
preimmune serum PSI taken from the same animal before the first 
antigen injection. The fact that the band appears exactly at the position 
of the calculated molecular weight of 20 kD suggests that the Mpv17 
protein does not undergo post-translational modifications changing its 
running behaviour on SDS-PAGE. The antiserum ASII failed to detect 
the GST-Mpv17 genein ELISA and Western analysis. It was therefore 
not used for any other experiments. 
Since the preimmune serum also reacted against several other proteins 
in Western analysis, it was necessary to always include the preimmune 
serum (PSI) in further experiments in order to distinguish between 
Mpv17-specific and background signals. 
Generation of monoclonal antiborlies 
Because of the background problern with the ASI antiserum, I set out to 
raise monoclonal antibodies against the GST-Mpv 17 fusion protein. 
Monoclonal antibodies have the advantage that they recognize only a 
single epitope, and thus should show much less background signal, and 
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represent a potentially unlimited source of antibody. In addition they 
can be generated using impure antigens, while polyclonal antibodies 
require relatively pure antigens to keep backgrounds adequately low. 
Two 12 weeks old Balb/c mice were injected intra-peritoneally (i.p.) 
four times with GST-Mpv17 protein supplemented with Freund"s 
adjuvant at intervals of four weeks. Test bleeds were taken one week 
after the last i.p. injection and revealed a positive response against the 
fusion protein in ELISA tests for only one animal, which was then 
injected intra-venously (i.v.) on three following days with the antigen 
omitting the adjuvant. On the fourth day the spieen was removed from 
the animal and the suspended cells fused with mouse myeloma cells Ag8 
(kindly provided by Gerd Moldenhauer, DKFZ, Heidelberg). The 
hybridomas were plated out into ten 96 well plates, and 32% of the 
wells were growth positive. The supernatants were differentially tested 
by ELISA, using GST only and the GST-Mpv17 fusion protein as 
targets. This allowed the identification of hybridomas producing 
antibodies which solely recognize the Mpv17 portion of GST-Mpvl7. 
Three hybridoma supernatants were positive for the Mpv17 part only, 
while 15 were identified that recognized the GST. The three Mpv17-
specific hybridomas were expanded and the supernatants tested in 
Western blot analyses, again using the GST and GST-Mpv17 proteins as 
targets. The monoclonal antihoclies inwere detected with horseradish 
peroxidase conjugated anti-mouse secondary antibody and visualised 
with the ECL system (Amersham). The supematants of clones 5D2 and 
6F5 bound strongly to the Mpv 17 protein, while the signal of 3D8 was 
rather weak (Figure 4.8). Subsequently the three clones were subcloned 
by limited dilution. The monoclonal antibodies produced by the pure 
clones were then isotyped. The monoclonal antibodies 5D2 and 6F5 
were shown tobe lgG1 and the clone 3D8 was identified as lgM. The 
antibodies were purified by a Protein G column and an anti-mouse-IgM-
agarose column, respectively. It was not possible to purify the 3D8 
antibody via Protein A or G, because the constant part of lgM antibodies 
does not bind to either of them (Harlow and Lane, 1988). The 3D8 
antibody was concentrated to 0.3 mg/ml, while the other monoclonals 
were used as 1 mg/ml stock solutions. All antibodies were then tested in 
Western blots of protein extracts from 3T3 cells and RSV7 cells. The 
latter cell line constitutively averexpresses the human Mpv17 gene 
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under the control of the Rous sarcoma virus (RSV) promoter (Zwacka 
et al., 1994). The 3D8 antibody recognizes a proteinband of 20 kD, the 
intensity of which is significantly increased in the overexpressing cells 
(Figure 4.9), indicating that indeed the Mpv17 protein is recognized in 
these cells. However, the reactivity was not as high as expected, and the 
yield of antibody was very low. This is probably due to the fact that 
IgM antibodies are mainly generated in the primary immune response, 
thcreby rcprcsenting rather non-optimised and low-affinity antibodies. 
It is also known that this class of antibodies are secreted by the 
hybridomas at low concentrations. I therefore suspect that the high 
similarity between the murine Mpv 17 protein and the human Mpv 17 
protein, that was used for the immunisation, results in the poor immune 
response in the mice, giving rise to weak antibodies. In order to have a 
better source of anti-Mpv17 antihoclies we are currently in the process 
immunising Mpv 17 homozygous mice, which lack Mpv 17 protein 
expression, with recombinant Mpv17 protein. This was initially avoided 
because of concem about the life span of these mice. Since then it seems 
feasible to maintain these animals for more than the minimal time of 6 
months required for the immunisation protocol. 
The generated monoclonal and polyclonal antibodies against Mpv 17 
protein were then tagether tested in cyto-immunofluorescence 
experiments on cells known to express Mpv17 transcripts in order to 
decipher the intracellular localisation of the gene product. 
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Figure 4.1 Comparison of the protein sequences of the human (top) and murine 
(bottom) Mpv17 genes. The percent identity between the two proteins is 92%. 
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Figure 4.2 Comparison of murine Mpv 17 amino acid sequence (bottom) with the rat 
pmp 22 (top, Kaldi et al., 1993) protein. Identities between the two proteins indicated 
as full lines constitute 26% of the Mpv 17 sequence. Conservation on the basis of the 
algorithms of similarity of the GCG program (Genetics Computer Group, 1991) is 
more 52%. 
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Figure 4.3 Hydropathy analysis of the human Mpv17 protein (a,c) and rat pmp 22 
protein (b, d). a, b: Hydropathy profile using the algorithm of Kyte and Doolittle. c, 
d: Topologie prediction according to Chou and Fasman. 
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Figure 4.4 Schematic view ofthe TrpE-Mpv17 and the GST-Mpv17 fusion protein. 
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Figure 4.5 Bacterially expressed GST-Mpv17 fusion protein. a: Mini-scale protein 
preparations from pGex-Mpv17 DNA-positive clones (1-6) and a control clone (C) 
containing the pGex vector only. The left lane of each clone represents the non-induced 
culture, while the right lanes (i) show the protein extracts from cultures treated with 
IPTG. b: Purified GST-Mpv17 fusion protein from clone 6. On the right side different 
amounts of BSA were loaded to quantify the concentration of the purified fusion 
protein. (M=molecular weight marker (daltons): 106, 80, 49, 32, 27, 18). 
67 
...,.__ 20kD 
1 2 
Figure 4.6 Protein extracts from NIH3T3 cells were prepared, 1 OOj..tg loaded, 
Western blotted, and probed with preimmune serum (lane 1) and antiserum (lane 2) 
from rabbits immuni?:ed with GST-Mpv 17 fusion protein. 
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Figure 4. 7 Western blots of monoclonal antibodies against 1 J.Lg of purified GST-
Mpv17 and GST protein, respectively. 6F5, 5D2, and 3D8 were identified tobe Mpv17 
specific in ELISA-tests, while 7 A6 also recognized the GST protein alone in such 
analysis. 
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Figure 4.8 Western blot of total protein extracts frorn NIH3T3 cells and RSV7 cells 
(Zwacka et al., 1994). 3D8 recognizes the Mpv17 protein as aband of 20 kD. The 
increased arnount of Mpv 17 protein in the overexpressing cellline RSV7 is visible. 
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Chapter 5. Intracellular and cellular localisation of the 
Mpv17 2ene product 
The sequence homology of the rat pmp 22 and Mpv17 and the similarity 
between their hydrophobicity profiles gave the first hint towards a 
possible intracellular localisation of the Mpv17 gene product. This 
similarity between the two proteins led to the hypothesis that the Mpv17 
gene product is a protein of the peroxisomal membrane. 
Mpv17 localises to peroxisomes 
NIH 3T3 cells which were shown to expres~ Mpv17 mRNA (Figure 3.6) 
were subjected to cyto-immunofluorescence studies. The cells were 
treated with the different anti-Mpv17 antibodies ASI, anti-TrpE-Mpv17, 
6F5, 5D2, 3D8. In addition, the pre-immune serum PSI as a direct 
control and the anti-GST antibody 7 A6 were used to distinguish 
background from Mpv 17 -specific signals. In the initial experiments an 
intracellular punctuate pattern, consistent with a peroxisomal staining, 
was detected with 3D8, AS I, and with anti-Trp E-Mpv17, while the 
6F5, 5D2 and as expected the PS I and 7 A6 only revealed a weak overall 
background signal (data not shown). To corroborate the peroxisomal 
localisation a doüble label staiüiüg üsiüg a shcep anti-catalase serum, as a 
marker for peroxisomal localisation (Lazarow and Moser, 1989), 
together with the ASI and 3D8 antibodies was performed. The primary 
antibodies were detected by a secondary goat anti-sheep antibody 
conjugated to FITC-fluorescent dye and secondary anti-rabbit and anti-
mouse antibodies Iabelied with rhodamine, respectively. The experiment 
revealed that the anti-catalase and the anti-Mpv17 patterns were 
superimposable (Figure 5.1 a, b), indicating that the Mpv 17 protein is 
indeed peroxisome-associated. Moreover, in HepG2 cells, a human 
hepatoma cell line which is frequently used in peroxisome studies, a 
similar subcellular distribution was seen (not shown). The specificity of 
the Mpv 17 antibodies was verified using primary skin fibroblasts from 
homozygous Mpv17 mice and from heterozygous control animals, 
respectively. In an analogous double staining experiment, both anti-
catalase and anti-Mpv17 antibodies showed the characteristic 
peroxisomal staining pattern in heterozygous cells (Figure 5.1c, d), 
whereas homozygous cells showed normal catalase staining (Figure 5.1f) 
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but lacked Mpv17 staining (Figure 5.1e). Thus, the Mpv17 antibodies 
specifically recognized the protein missing from homozygous Mpv17 
cells. In summary, these immunofluorescence studies using various 
' poly-and monoclonal antibodies against Mpv17 protein demonstrated 
colocalisation with peroxisomal markers and hence peroxisomal 
localisation of the Mpv17 protein. Basedon hydrophobic stretches in the 
amino acid sequence it is suggested that the Mpv17 protein may localise 
to the membrane of the peroxisome, but this needs further investigation 
by immune electron microscopy for example. 
The function of the Mpv17 gene product and any involvement of human 
homologue in one of the classical peroxisomal defects in man was next 
investigated. Interestingly, a similar degree of homology as seen for 
Mpv 17 and pmp 22 was detected between the 70 kD peroxisomal 
membrane protein (Kamijo et al., 1990) and the recently cloned 69 kD 
adrenoleukodystrophy protein (Mosser et al., 1993), which was later 
shown to be also an integral membrane protein of peroxisomes (Mossser 
et al., 1994). They both belang to the superfamily of ATP binding 
cassette transporters, a fact that gave rise to the hypothesis that the two 
protein are possibly associated in the peroxisomal membrane. However, 
no evidence has been presented for this theory so far. To test for a 
potential association of the Mpv 17 protein and the pmp 22 protein 
Western analysis of peroxisomal membrane fractions from homozygous 
Mpv 17 and control mice were performed. However, no significant 
differences in the content of pmp 22 ( data not shown) were seen. 
indicating that the presence of Mpv 17 protein is not required for the 
insertion of the peroxisomal membrane protein 22 into the membrane. 
Comparison of human peroxisomal disorders and the Mpv17 
phenotype 
In the previous section it was shown that the Mpv 17 protein localises to 
the peroxisome. The Iack of the protein Ieads to glomerulosclerosis and 
nephrotic syndrome in mice, raising questions about the nature of the 
link between a deficient peroxisomal function and the kidney defect. In 
addition, I was interested to find a human disease that is caused by a 
defect in the human Mpv 17 gene. I therefore compared the phenotypes 
of several human peroxisomal disorders with the condition of the 
Mpv 17 mouse. 
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Several human genetic diseases are known in which the primary defect 
is within the peroxisome (Lazarow and Moser, 1989). So far no animal 
model exists for any of them. Some of them represent defects in single 
biochemical pathways, while others such as Zellweger syndrome affect 
peroxisome biogenesis. 
Peroxisomes are found in virtually all eukaryotic cells ranging from 
eukaryotic microorganisms to plants and animals. They were first 
discovered in 1954 in thc proximal tubules of mouse kidneys as 
spherical structures (Rhodin, 1954 ), b~t were recognized as 
morphological and biochemical entities only 12 years later by De Duve 
and co-workers (Baudhuin and De Duve, , 1966). At present, there are 
about 50 enzymes known to localise to mammalian peroxisomes 
covering a diverse array of functions. They are involved in anabolic 
functions such as the activation and ß-oxidation of long chain fatty acids 
and their derivatives, the synthesis of ether lipids ( of which the most 
importants ones are the so called plasmalogens), the biosynthesis of 
cholesterol, bile acids biosynthesis, gluconeogenesis, glyoxylate 
transamination. They are also involved in catabolic functions such as of 
purine catabolism, polyamine catabolism and finally the inactivation of 
reactive oxygen species such as hydrogen peroxide and superoxide 
anions (Lazarow and Moser, 1989). 
The human peroxisomal diseases are subdivided into three classes, 
though often the first two groups are combined (Bioukarand and 
Deschatrette, 1993). The Cerebro-hepato-renal (CHR) syndrome better 
known as Zellweger syndrome (ZS), neonatal adrenoleukodystrophy 
(NALD), infantile Refsum disease (IRD), and hyperpipecolic acidaemia 
(HPA) all belong to group A, described by a general loss of 
peroxisomal functions, due to the fact that no or only very few 
morphologically intact peroxisomes are present in cells from these 
patients. Many peroxisomal proteins are mislocalised to the cytosol 
while others such as the two major peroxisomal membrane proteins pmp 
22 and pmp 70 are found in vesicles called peroxisomal ghosts that are 
suspected to be peroxisome precursors. These observations lead to the 
conclusion that the peroxisome biogenesis defects (PBD), a generic term 
for the group A disorders, are due to a structural defect and a generally 
impaired peroxisome assembly preventing the import of peroxisomal 
matrix proteins. The most prominent disorder from group A is the 
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Zellweger syndrome. It is a recessive genetic disease like most other 
peroxisomal disorders and is characterized by craniofacial dysmorphia 
(for example high forhead, large anterior fontanel epicanthal folds, and 
deformed ear lobes), neurological abnormalities (e.g. cortical dysplasia 
and neuronal heterotopia), impaired hearing, retinopathy, frequent 
cataracts, liver disease, calcific stippling of the epiphyses and, 
interestingly, small renal cysts. ZS is a congenital syndrome, but 
regressive changes can also be observed in the postnatal lifc mainly 
affecting the brain abnormalities. Patients usually die within the first 
few months after birth. The other three disorders of group A are milder 
forms, differ in their regression rate :from ZS, and exhibit no 
glomerulocystic kidney abnormalities, reflecting the general 
heterogenity of peroxisomal diseases. The main biochemical 
characteristics of patients from group A are elevated levels of very long 
chain fatty acids, bile acid intermediates, pipecolic acid, phytanic acid, 
pristanic acid and an impairment in the biosynthesis of plasmalogens, 
indicating the loss of almost all peroxisomal enzymatic functions. It is 
assumed that the enzymes needed for the ß-oxidation or cholesterol 
degradation, for example, are not normally compartmented, so they are 
subjected to rapid degradation. lt is interesting to note, that the absence 
of peroxisomes can lead to a wide spectrum of clinical phenotypes 
ranging from severe ZS to the milder form of IRD. 
Group B patients do possess peroxisomes, but they are deficient for a 
number of peroxisomal functions, thus leading to RhizomeHe chondro-
dysplasia punctata (RCDP) or Zellweger-like syndrome. The most 
prominent disorder from this group is RCDP that is characterized by 
short stature, typical facial appearance, mental retardation, and 
biochemically by an increase in phytanic acid and deficient plasmalogen 
synthesis. 
Group C comprises diseases which are caused by the impairment of a 
single peroxisomal function such as X -linked adrenoleukodystrophy 
(ALD), Acyl-CoA oxidase deficiency (pseudo-NALD), bifunctional 
protein deficiency, peroxisomal thiolase deficiency (pseudo-ZS), 
dihydroxyacetone phosphate acyltransferase (DHAP AT) deficiency 
(pseudo-RCDP), glutaryl-CoA oxidase deficiency, di- and 
trihydroxycholestanoic acidaemia, hyperoxaluria type I, and 
acatalasaemia. 
73 
X-linked adrenoleukodystrophy, which was first described by 
Siemerling and Creutzfeldt in 1923 and affects one out of 20 000 males 
with varying severity. It is the disorder that attracted most attention 
from the group C diseases. ALD is identified by a progressive 
demyelination of the central nervous system and adrenal insufficiency, 
while biochemically only an increase in VLCFAs can be observed. All 
other diseases from the last two groups have only been reported in few 
cases and none of them shows any kidney abnormality. 
Does Mpv17 play a role in the peroxisomal biogenesis? 
Since none of the described clinical pictures is similar overall to the 
Mpv17 phenotype, we wanted to know whether the Iack of Mpv17 Ieads 
to an impaired assembly of peroxisomes in the mutant mice. In this case, 
the differing phenotypes in ZS patients and Mpv 17 homozygotes would 
be due to metabolic or genetic variances between humans and mice. 
So. far two genes and their products have been implicated in biogenesis 
of peroxisomes. A 35K protein (Tsukamoto et al., 1991) was identified 
in complementation analyses with a rat cDNA library of the 
peroxisome-deficient Chinese hamster ovary (CHO) cell mutant Z65, 
that closely resembles fibroblasts from ZS patients. Later the highly 
homologaus human gene was also cloned and a ZS patient (Shimozawa 
et al., 1992) found with mutations.in the gene. The pmp 70 gene was 
also identified to be mutated in two ZS patients by single strand 
conformational analysis (SSCP) and sequencing (Gärtneret al., 1992). 
In order to elucidate the possible role of the Mpv 17 gene in the 
peroxisome biogenesis SSCP analyses of were performed, but revealed 
no apparent changes in the nucleotide sequences of Mpv17 cDNA 
generated from the isolated RNA of ZS cells (Dr. Mika Karasawa, 
personal communication). 
W e examined the morphological integrity of peroxisomes in mutant 
Mpv 17 mice by electron microscopy. As shown in Figure 5 .2, mutant 
liver peroxisomes showed no structural abnormality at the Ievel of 
electron microscopy. Catalase activity appeared to be present as 
demonstrated by staining with diaminobenzidine, indicating that at least 
for this enzyme the peroxisomes were not deficient or leaky. Moreover, 
the Mpv 17 protein seemed not to influence the proliferation of 
peroxisomes (Figure 5.3) which could be induced in rodents by 
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hypolipidaemic drugs such as bezafibrate (Reddy and Lalwani, 1983). 
W e therefore concluded that Mpv 17 is not a peroxisome biogenesis 
factor, but rather part of a pathway localised in peroxisomes, that is 
important for normal kidney function in mice. 
Physiological parameters in ZS and the potential role of 
Mpv17 
In order to elucidate a possible involvement of Mpv17 in the 
development of one of the physiological abnormalities in ZS, the single 
phenotypical alterations of the disease were investigated in the Mpv 17 
mause. This is important since ZS patients display a kidney phenotype 
that is potentially caused by one of the altered physiological parameters 
in these peroxisomal disorders and therefore possibly linked to Mpv 17 
function. We therefore tested mutant and non-mutant mice for several 
major markers of peroxisomal deficiencies such as the C22/C26 ratio, 
plasmalogen ( ether Iipid) synthesis, bile acid synthesis, and catalase 
activity in the homozygous Mpv17 mice and controls. 
An increased C26/C22 ratio is indicative of a defective peroxisomal 
ß-oxidation pathway of very long chain fatty acids (Lazarow and Maser, 
1989). The enzymes of the peroxisomal fatty acid catabolism have a 
preference for very long chain fatty acids ( those with chain lengths of 
24 or more carbons) that cannot be degraded by mitochondrial enzymes, 
while smaller ones are readily oxidised in mitochondria and to a lesser 
extent in peroxisomes. This, however, leads in case of a defective 
peroxisomal system to the accumulation of C26 fatty acids relative to 
those with shorter C22 carbon chains and an increase in the C26/C22 
ratio in serum. The accumulation of these very long chain fatty acids is 
also found when only single enzymes of the ß-oxidation pathway 
downstream of the actual shortening reaction of the carbon chain, such 
as in thiolase deficiency, are defective due to saturation of the upstream 
enzymes with intermediates. The C26/C22 ratio in serum was, however, 
found to be the same in Mpv17 homozygotes and control mice. 
(Measurements were performed in the laboratory of Kinderklinik 
Universität Heidelberg). 
Plasmalogens constitute some 5 to 20 % of the phospholipids in most 
mammalian cell membranes and are precursors of platelet-activating 
factor (P AF). The first two steps of the ether lipid synthesis that begins 
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with dihydroxyacetone phosphate (DHAP) are catalysed by membrane 
bound enzymes whose active sites face the luminal side of the 
peroxisomes. The subsequent reactions take place on the cytosolic side 
of peroxisomes and finally in the endoplasmic reticulum. ZS patients or 
patients deficient for ether lipid synthesis (RCDP) display markedly 
decreased erythrocyte plasmalogen Ievels and also lower Ievels of P AF 
as measured in polymorphonuclear leukocytes (van den Bosch et al., 
1993). In Mpv17 mice no decrease in the level of plasmalogens could be 
detected. (The measurements were performed by Prof. A. Roscher, 
Munich). 
Bile acid synthesis can also be regarded as the catabolism of 
cholesterol, and was considered another site of potential involvement of 
the Mpv17 protein, since the Mpv17 mice show an increased serum 
cholesterollevel. Coenzyme A-conjugated bile acids, that are excreted in 
the bile are required for digestion and absorption of lipids in the 
intestine, because of their amphiphilic character and detergent-like 
properties. The first stage in cholesterol break-down, the rate limiting 
step in bile acid synthesis, is 7a-hydroxylation. lt is catalysed by a P-
450 cytochrome that is located in the endoplasmic reticulum, where all 
other steps of the cholesterol catabolism down to 3a, 7a-dihydroxy-5ß-
cholestanoic acid (DHCA) and 3a, 7a, 12a-trihydroxy-5ß-cholestanoic 
acid (THCA) also occur. The highest capacity for the subsequent 
oxidation of the side chains of these two compounds and the formation 
of the bile acids cholic acid and chenodeoxycholic acid was, however, 
shown to reside within the peroxisomal fraction (Pederson and 
Gustafson, 1980). 
Hence, one could suggest that the lack of Mpv 17 may interfere with 
these last steps in the degradation of cholesterol to bile acids, resulting 
finally in elevated serum cholesterol Ievels or the accumulation of bile 
acid intermediates that have the same deleterious effects as cholesterol. 
In this context it is interesting to note that some research groups have 
reported that hypercholesterolemia is at least an aggravating factor in 
the progression of initial glomerular injury to glomerulosclerosis 
(reviewed in Diamond and Karnovsky, 1992). Animal experiments even 
suggest a causative role of high cholesterol Ievels for morphologic 
changes in the aorta and kidney. Normal laboratory rats fed diets 
supplemented with 3% cholesterol or cholic acid developed 
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hypercholesteremia within 4 weeks that was accompanied by segmental 
and/or global glomerulosclerosis (Peric-Golia and Peric-Golia, 1983). 
We therefore measured whether we could detect any accumulation of 
intermediates of bile acid synthesis in the gall bladder contents from 
homozygous Mpv 17 mice in comparison to wild type mice by HPLC. 
However, no differences in the distribution of bile acid precursors could 
be detected, indicating a fully functional bile acid synthesis in the Mpv17 
homozygous mice. (Measurements were performed by Prof. Stiehl, 
Heidelberg). 
An alternative way to explain the high serum cholesterol level in the 
Mpv17 mice would be increased biosynthesis of cholesterol. It has been 
found that the rate limiting enzyme of this pathway is located in 
peroxisomes and that the organeHe accounts for about 30% of total de 
novo synthesis of cholesterol (Keller et al., 1986). Deregulation of this 
mechanism in the Mpv17 mouse, however, has not yet been looked at. 
Catalase activity was found to be bound to peroxisomes in Mpv17 
mice (Figure 5.2) as mentioned above revealing a seemingly intact 
machinery for the decomposition of H20 2• 
In summary no abnormalities concerning the peroxisomal functions 
oxidation of very long chain fatty acids, plasmalogen generation, bile 
acid biosynthesis, and catalase function were found in the Mpv17 
homozygous mouse. 
After measuring the major physiological parameters of peroxisomal 
functions we assume that the Mpv 17 protein has a yet unidentified 
peroxisomal function. Altematively, a defect in Mpv17 expression may 
result in different biochemical phenotypes in mice and man. It can also 
not be ruled out, that the Mpv 17 gene has no important function in 
humans, and that the Mpv 17 gene product fulfils a function in a mouse 
specific metabolic pathway. A precedent for a specific rodent-specific 
peroxisomal function is the enzyme urate oxidase which converts uric 
acid to allantoin. In humans this enzyme is missing and the consequence 
is the susceptibility of this species to urate deposites leading to gout. In 
rodents, urate oxidase is a major constituent of the peroxisomal 
paracristalline core readily detected by electron microscopy in the dense 
region of the organelle" s matrix. An animal model for gout has been 
developed by disruption of the urate oxidase gene in mice, rendering the 
mutated animals susceptible to this disease (Wu et al., 1994). Thesemice 
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developed hyperuricemia and renal stones resembling the human 
condition, although in mice the onset of the urate nephropathy occured 
much earlier and was more severe. This finding indicates that urate 
oxidase plays a vital role in the clearance of uric acid in mice, while 
most humans do not normally develop gout except in conjunction with 
other unknown factors. The differences between this phenotype and the 
Mpv17 defect also makes a direct involvement of Mpv17 in this pathway 
unlikely. 
The minor functions of peroxisomes are not likely candidates for an 
involvement of Mpv 17 since the peroxisomal disorders from group B 
and C that have a single or several impaired peroxisomal functions share 
no phenotypical similarities with the Mpv 17 disease (Lazarow and 
Moser, 1989). 
As stated at the beginning of this chapter renal cysts were observed in 
most of the ZS patients who were studied pathologically. These cysts 
vary from glomerular microcysts to large cortical cysts of glomerular 
and tubular origin (Lazarow and Moser, 1989). Athough the Mpv17 and 
ZS renal phenotypes are certainly not identical, one could suggest that a 
potential loss of Mpv17 function in Zellweger patients is due to the 
mislocation and degradation of the Mpv17 protein could Iead to the 
kidney phenotype, and that the young age, these patient die at, prevents 
the onset of the glomerulosclerosis. However, in order to address this 
question, it is neccessary to elucidate the precise function of the Mpv 17 
gene product and then to check for an impairment of this function in 
zs. 
Cellular localisation of the Mpv17 protein in the kidney 
Northem blots of various mouse tissue RNAs (Weiher et al., 1990) and 
in situ analysis (Mika Karasawa, unpublished results) has revealed a 
ubiquitous expression of Mpv 17. These results raised the question of 
whether the renal phenotype in Mpv17 homozygous mice is a defect 
originating in the kidney or glomerulus itself, or is a secondary effect 
caused by a different impaired metabolic function. Since no other 
apparent phenotypic alterations in organs other than the kidney were 
observed, it is possible that the glomerulosclerosis is due to an initial 
renal dysfunction. The puzzle, however, of how the loss of a widely 
expressed gene can cause such a single-organ phenotype, remained. It 
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could finally not be ruled out that other tissues were affected in a more 
subtle manner, thereby escaping detection. 
In order to elucidate the sites of Mpv 17 expression in the kidney we 
used the anti-Mpv17 monoclonal antibody 3D8 on a normal human 
kidney section. It revealed expression in the glomerular epithelial cells 
(Figure 5.4), which have a critical role in the development of 
glomerulosclerosis. Peroxisomes were also reported to be present in 
these cells (Zaar, 1992 and references therein) which is in accordance 
with the intracellular localisation of the Mpv17 protein. A Iack of the 
Mpv17 gene product could lead to an altered cell metabolism and cell 
integrity. Kerjaschki (1994) summarises the cellular events required for 
the morphological changes which manifest in the fusion of the 
podocytes" foot processes, that were studied in rat glomeruli treated 
with a polycationic solution. These included a complex pattern of 
phosphorylation of intracellular proteins (Kurihara et al., 1992) and the 
need for a supply of energy and of calcium (Kerjaschki, 1978). An 
involvement of Mpv17 in these processes is possible, but remains tobe 
shown. 
Potential redox function of Mpv17 
Highly reactive oxygen species (ROS), potentially inflicting darnage on 
proteins and leading to Iipid peroxidation, have been shown to be 
associated with glomerulosclerosis (Wardle, 1992). Since peroxisomes 
are a major site of production and decomposition of such radicals we 
addressed a potential involvement of Mpv 17 in these processes. 
Though catalase has been shown to be bound to peroxisomes in Mpv 17 
mice (Figure 4.3), we have so far not demonstrated this for the 
peroxisomal Cu, Zn superoxide dismutase. Alternatively, Mpv 17 could 
be involved in a pathway that generates ROS, giving rise to a change in 
the cellular redox state. 
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Figure 5.1 Colocalisation of Mpv 17 protein and catalase in peroxisomes. 
Immunofluorescence studies were performed on murine fibroblasts: 3T3 cells ( a, b ), 
primary fibroblasts from Mpv17 heterozygous (c, d) and homozygous (e, f) mice. 
were analysed. Mpv17 proteinwas visualized by a sheep anti GST-Mpv17 antiserum 
( a) and a monoclonal anti Mpv 17 antibody ( c, e) decorated with TRITC Iabelied 
secondary antibodies. Catalase was stained by a rabbit anti-bovine-catalase antibody, 
which was decorated with a FITC Iabelied goat anti-sheep IgG antibody (b, d, f). 
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Figure 5.2 Electron microscopy of periportal hepatocytes from a 45 day old Mpv 17 
mouse (left) and a control mouse (right). The peroxisomes are stained by 
diaminobenzidine due to their catalase activity (Gorgas, 1985). Magnification: 11000 
fold. (Kindly provided by Prof.Karin Gorgas, Heidelberg). 
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Figure 5.3 Electron rnicroscopy of periportal hepatocytes from an Mpv17 mouse 
(left) and a control mouse (right) treated with bezafibrate (kindly provided by 
Boehringer, Mannheim), a hypolipidemic drug that gives rise to an increase in the 
number of peroxisomes in rodents. The daily dosis for two weeks of bezafibrate, 
applied orally, was 1 Omg/kg/bodyweight. (The electron micrographs were kindly 
provided by Prof.Karin Gorgas, Heidelberg). 
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Figure 5.4 Immunohistochernistry of a frozen section frorn a normal human kidney 
using the anti-Mpv17 3D8 antibody. A glomemlus is depicted, in which the podocytes 
are stained by the 3D8 antibody. The primary 3D8 is decorated by a peroxidase-
conjugated anti-mouse antidody revealing a brown colour. The cellnuclei are counter 
stained in blue with hematoxilin. 
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expression is the first step in the development of glomerulosclerosis in 
this animal model. 
Although an elevated MMP-2 protein expression could be detected in 
homozygous mice, it is not clear whether it reflects the overall MMP-2 
proteinase-activity, as MMPs are subjected to postranslational regulation 
on different levels. In particular, the regulation by TIMP-2 that is 
known to bind and supposed to inhibit MMP-2, has not been investigated 
in our system yet Nevertheless, th~se r~snlts reveal new insights into the 
putative role of MMP-2 in human glomerular injury. 
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Chapter 6. Function of the Mpv17 protein 
After we could not detect any abnormalities in the major peroxisomal 
functions in the Mpv 17 mouse such as oxidation of very long chain fatty 
acids, plasmalogen synthesis, cholesterol metabolism, and catalase 
activity, the role of the peroxisomal protein Mpv17 in the generation 
and detoxification of reactive oxygen species was investigated. This was 
prompted by experimental evidence of an association of renal defects 
and extra- and intracelluar redox status (Wardle, 1992). Furthermore, a 
link between Ros mediated cellular injury and kidney disease suggetsed 
by a report of a mouse mutant in which the bcl-2 gene has been 
inactivated by insertion (Veis et al., 1993). Bcl-2 protein, an inhibitor of 
apoptosis, has been shown to play a role in protection against H20 2 and 
Iipid peroxidation (Hockenbery et al., 1993). Interestingly, the null 
mutation for bcl-2 in mice also exhibits a phenotype in the kidney. 
Although the pathology of kidney disease in these mice is different from 
that in the Mpv 17 mice, this suggests that proper function of this organ 
critically depends on an intricate regulation of radical metabolism. 
ROS and peroxisomes 
Peroxisomes possess a variety of enzymes ( oxidases) that reduce 0 2 to 
H 20 2 • Hydrogen peroxide is a toxic compound and needs to be 
decomposed. Catalase converts two molecules of H20 2 into two 
molecules of H20 and one molecule 0 2• Various oxidases also 
decompose H20 2 via another pathway. In the latter case one molecule 
H 20 2 gives rise to two molecules of H20 using ethanol, methanol, 
formaldehyde, formic acid, or nitrite ions as the hydrogen donor instead 
of a second hydrogen peroxide (de Duve et al., 1966). More recent 
experiments (Keller et al., 1991; Wanders et al., 1992; Dhaunsi et al., 
1992) have shown the presence of Cu, Zn superoxide dismutase in 
human and also rat peroxisomes. Superoxide dismutase converts two 
superoxide anions (02 -) into one molecule of H20 2 and one molecule of 
0 2 • The highly reactive superoxide anion is a by-product of oxygen 
reduction in mitochondria and endoplasmic reticulum (Cross and Jones, 
1991). A peroxisomal source for 0 2- is the reaction from xanthine to 
urate catalysed by xanthine oxidase (XO). With the presence of 
superoxide dismutase, peroxisomes host an effective defense mechanism 
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against superoxide. It is therefore likely that other sources of 
peroxisomal superoxide production exist that remain to be identified 
(Mannaerts and Veldhoven, 1993). 
ROS and kidney disease 
The capacity of peroxisomes to produce and decompose radicals is 
interesting in the context of kidney defects, since numerous studies 
(rcvicwed in Nath et al., 1989; Shah et al., 1991) imply an important 
role for reactive oxygen species in mediating injury in several models 
for renal disease. These include glycerol induced injury (Guidet and 
Shah, 1989), ischemia-reperfusion injury (McCoy et al., 1988; Nath et 
al., 1990), gentamiein nephropathy (Walker and Shah 1987), and 
neutrophil-dependent glomerular injury (Shah et al., 1987; Y oshioka 
and Ichikawa, 1989). Hydrogen peroxide as such is also toxic, when 
administered to the intact kidney (Y oshioka et al., 1990) or the isolated 
perfused kidney (Linas et al., 1987), and inflicts cellular injury at 
multiple cellular sites either directly or through the generation of more 
reactive intermediates (Grisham et al., 1986). Moreover, it was found 
that substances capable of reducing H20 2 to water (e.g. pyruvate) 
protect against renal injury (Salahudeen et al., 1991). The scavenging 
effects could be shown in vitro by attenuation of H20 2-injury to cultured 
kidney cells andin vivo models by limiting renal damage, indicated by 
reduction of proteinuria (Salahudeen et al., 1991). Most interestingly, 
N eale et al. ( 1993) could identify visceral glomerular epithelial cells as 
the site of ROS production in an induced rat model for the human 
nephropathy Passive Heymann Nephritis (PHN). 
PHN is a membranaus glomerulonephritis similar to minimal change 
disease and therefore resembles the Mpv 17 phenotype to some extent. 
By immuno-histochemical examination of kidneys from rats with 
induced PHN and control animals, cytochrome b558 , a part of the non-
mitochondrial multicomponent NADPH-oxidase enzyme complex, was 
detected mainly in glomerular epithelial cells and to a lesser extent in 
mesangial and endothelial cells. The NADPH-oxidase complex is a 
superoxide generating system that was first discovered in neutrophils 
and found tobe involved in the respiratory burst, which is a response to 
microbial challenge. However, the enzyme had been detected in many 
other cell types such as human mesangial cells (Radeke et al., 1991) and 
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fibroblasts (Meier et al., 1989). In the PHN-rats, the level of the 
cytochrome b558 representing the NADPH oxidase system was found to 
be markedly elevated in the podocytes, indicating a potential increase in 
the production of ROS by these cells. This could establish the initial 
glomerular injury leading to the kidney disease. In the glomeruli of 
proteinuric PHN rats increased amounts of hydrogen peroxide could 
indeed be detected by the histochemical cerium precipitation method 
particularly in the GBM (Neale et al., 1993). These results strongly 
suggest, that the activation of the NADPH oxidase is the reason for the 
increase in hydrogen peroxides which are easily produced from the 
initially generated superoxide by dismutation. However, the molecular 
mechanisms that Iead from elevated ROS Ievels to proteinuria and the 
morphological changes of the capillary wall remain to be determined. 
ROS and Mpv17 
lt is intriguing that peroxisomes are a site of production and 
detoxification of 0 2- radicals and peroxides and that the lack of the 
peroxisomal protein Mpv17 in mice Ieads to nephrotic syndrome, which 
has been shown to be associated with deregulated ROS metabolism. In 
order to analyse a potential role of Mpv 17 in this phenomenon, we 
investigated mutant and normal cells for intermediates of these 
pathways. To study the production of ROS in mutant Mpv17 cells we 
derived primary skin fibroblasts from mutant and non mutant mice and 
tested them for the ability to produce reactive oxygen. 
Cells were loaded with hydroethidine which reacts with intracellular 
02- radicals and other ROS to form the fluorescent dye ethidium (Rothe 
and Valet, 1990). The production of intracellular ROS was then 
measured by FACS analysis. Surprisingly, the result was in contrast to 
our expectations. While normal mouse primary fibroblasts showed a 
single peak of Iahelied cells, cells from homozygous mutant animals 
displayed a second peak of fluorescence at low intensity (Figure 6.la, 
b ). This second peak is coincident with that obtained with nonlabelled 
cells assayed at the same wavelength (data not shown). This indicates 
that at least in a subpopulation of the primary fibroblasts, lack of Mpv17 
expression Ieads to a complete failure to produce ROS, while in the 
other subpopulation different mechanisms of ROS production may be in 
operation. 
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In order to investigate, if the lack of Mpv 17 expression simply 
interferes with a pathway involved in ROS production or if the Mpv17 
protein by itself has a ROS producing activity, we studied ROS 
production in cells overexpressing the Mpv17 gene product. Thus, 3T3 
cells were transfected with a construct constitutively overexpressing 
high levels of Mpv 17 protein under the control of the Rous sarcoma 
virus (RSV) promoter (RSV1 and RSV7 cells; Zwacka et al. 1994) 
Untransfected 3T3 cells expressed only very low lcvcls of Mpv17 
protein (not shown) and displayed a distribution in which a majority of 
cells were unlabelled and only a minority of cells were Iabelied (Figure 
6.1c). In contrast, in several independent RSVMpv17 transfectant clones 
expressing high levels of Mpv 17 protein, when grown only one peak 
representing Iabelied cells was seen. This is shown for one clone in 
Figure 6.1d. These results indicate that the Mpv17 gene product itself 
constitutes a major ROS producing activity in the cell or at least 
accomplishes a rate limiting step in this process. In summary, the results 
uncover an new peroxisomal function, involved in the production of 
ROS, the absence of which intriguingly causes glomerulosclerosis in 
m1ce. 
Whether these results reflect the in vivo situation in the glomerular cells 
has yet to be verified. Therefore in situ studies are currently underway 
in which the redox state of kidney cells in Mpv 17 mice, as compared to 
control mice, will be examined. As Mpv17 protein is mainly found in 
podocytes it is possible that they are the site where the defect in ROS 
production is manifested. This raises the question of how the reduced 
Ievel of reactive oxygen species in glomerular epithelial cells could 
interfere with the normal function of the kidney and eventually lead to 
glomerulosclerosis. 
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Figure.6.1 Reactive oxygen species produced in primary skin fibroblasts from 
Mpv17 and control mice. Hydroethidine (HE) histograms each representing 10000 cells 
after HE staining and analysis by FACS. a: Mpv17 homozygous primary fibroblasts, 
b: Mpv17 heterozygous primary fibroblasts c: Mouse NIH 3T3 fibroblasts. d: RSV7 
cells (NIH 3T3 cells transfected with a gene construct expressing the Mpv 17 protein of 
a RSV promoter) 
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Chapter 7. Implications ofMpv17 in gene regulation. 
The Mpv17 protein is involved in the production of ROS and the lack of 
Mpv 17 leads to an intracellular change in the redox potential. So far we 
have no evidence for a role for increased radicals in glomeruli in 
Mpv 17 mice that could exert direct darnage onto the glomerular 
basement membrane and the cellular components of the glomerulus. In 
contrast, we found a decreased level of ROS in cells from homozygous 
animals. We therefore suspected that the changed intracellular redox 
state which we observed influences the expression of genes important in 
the formation or the tumover of the GBM. 
Podocytes, the rnajor site of expression of Mpv 17 in the glomerulus 
(Figure 5.4) are known to synthesise the components that comprise the 
glomerular basement membrane such as the different chains of type IV 
collagen and laminin, as weil as the basement membrane heparan sulfate 
proteoglycan core protein (Glassock et al., 1991). It has been shown that 
the production of these substrates is significantly increased in 
glomerulosclerosis (Nakamura et al., 1991; Floege et al., 1991), and is 
regulated at the transcriptional level (Munaut et al., 1992). In addition, 
transforming growth factor-ß (TGF-ß) has been shown to play a role in 
the development of glomerular defects by regulating the expression of 
constituents of the GBM, the enzymes involved in matrix degradation 
and their inhibitors (Border et al., 1993). Moreover, Imai et al. (1993) 
found glomerular lesions after directing the expression of TGF-ß via 
Iiposome-mediated gene tranfer to the kidneys of normal laboratory 
rats. This indicates a direct influence of the growth factor TGF-ß on the 
pathogenesis of glomerular injury. In this particular experimental model 
the cell staining for type I and III collagen was elevated while the 
production of type IV collagen was only slightly increased. The increase 
in ECM deposition is, however, not the only feature and not likely tobe 
the initial event in glomerulosclerosis. Other changes also contribute to 
the disease, which are more likely to be involved in the primary 
glomerular defect. 
The phenotype of Alport syndrome suggests that events disturbing the 
integrity of GBM are required to lead to the leakage of macromolecules 
and blood cells. In Alport syndrome, the mutated collagen IV chains 
results in disintegration of the basement membrane that allows even 
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whole erythrocytes to pass through into the glomerular filtrate. More 
subtle darnage to the GBM, though not leading to hematuria, could 
however result in proteinuria. Enzymes that are involved in the 
turnover of the membrane and which are able to degrade the single 
components could give rise to such injuries. This would be possible if 
their activity was increased beyond the normal levels due to a 
glomerulus-specific loss of transcriptional and post-translational 
regulation. The enzymes that are involved in the initial steps of ECM 
degradation are Matrix metalloproteinases (MMPs). The MMPs are a 
group of zinc endopeptidases secreted from a variety of cell types as 
proenzymes, that are activated by cleavage of a propeptide by other 
proteinases. They are considered to play a central role in extracellular 
matrix breakdown in various pathological conditions, as well as in 
normal tissue remodeHing and resorption. Many of these enzymes have 
been shown to be capable of degrading several of the GBM~ s major 
components. MMP-2 also known as gelatinase A or collagenase IV 72 
kD, can readily digest all of these constituents (Murphy et al., 1991) and 
has also been shown to be expressed in metastasising tumor cells (Brown 
et al., 1990), indicating that it might be involved in the active 
proteolytic degradation of the matrix for cell invasion. Moreover, an 
enhanced expression of MMP-2 was found in puromycin 
aminonucleoside (PAN) nephrosis, a model for nephrotic syndrome 
progressing to glomerulosclerosis (Nakamura et al., 1994). In addition, 
a GBM-degrading metalloproteinase was demonstrated tobe secreted by 
glomerular epithelial cells (Johnson et al., 1992). I therefore started to 
investigate the possibility that the redox state regulated by Mpv17 is 
involved in the expression of MMP-2, which could constitute the intial 
glomerular lesion. This could in return cause the activation and release 
of growth factors and the accumulation of ECM, which is seen in 
glomerulosclerosis. 
Normal NIH 3T3 cells and those overexpressing the human Mpv17 gene 
under the control of the RSV promoter (RSV1 and RSV7, Zwacka et al., 
1994) were grown to semi-confluency and RNA isolated. Figure 7.1 
depicts the Northern analysis of these RNAs probed with the Mpv17 
cDNA and an MMP-2 fragment. lt reveals a striking reciprocal 
correlation between the Mpv 17 expression and the amount of 
collagenase IV transcript. RSV1 and RSV7 cells with a constitutively 
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high Ievel of Mpv17 RNA have no detectable collagenase IV expression, 
while in 3T3 cells, exhibiting varying degrees of Mpv17 expression for 
so far unknown reasons, the amount of collagenase varied inversly to 
the Mpv 17 transcript. This suggests that the changes in the redox status, 
due to Mpv 17 expression, result in modulation of collagenase IV 
transcription or in a faster, selective degradation of its mRNA. In order 
to demonstrate the involvement of ROS in this process I treated skin 
fibroblasts from Mpvl7 homozygous micc that lade Mpv17 expression 
and show high collagenase expression, with H20 2 according to a 
protocol outlined in Keyse and Tyrell (1989), RNA was prepared and 
analysed by Northern blot. (Figure 7.2) depicts that the Ievel of 
collagenase IV mRN A is indeed reduced by around 50% 2h and 6h after 
treatment with H20 2, potentially mimicking the effect of Mpv17, while 
lOh later the Ievel of the control RNA, taken instantly after the H20 2 
treatment, is almost reached again. These results disclose a new link 
between the intracellular redox potential and the modulation of MMP 
expression, which is potentially implicated in glomerular disease. (In 
order to further demonstrate a causal role of Mpv 17 in the repression of 
MMP-2 transcription, homozygous cells are currently being transfected 
with the RSV-Mpv17 construct). Interestingly, Kohn et al. (1994) have 
reported that different celllines exhibit a reduced MMP-2 activity when 
calcium influx was inhibited, suggesting a role of the protein kinase C 
(PKC) second messenger signalling pathway in the production of MMP-
2. Furthermore, treatment of cells with ROS producing systems 
(xanthine/xanthine oxidase) resulted in the activation of PKC (Larsson 
and Cerutti, 1989), establishing a connection between the oxidative 
status of a cell and reduction in MMP-2, as seen in the Mpv17 
overexpressing cells. 
Since variations at the transcriptional level do not always reflect actual 
change in protein activity, and molecular events in cultured fibroblasts 
cannot just be transferred to the situation in the different cells in the 
glomerulus, we used an antibody against MMP-2 (kindly provided by 
Matti Höyhtyä) to check kidney sections from control and Mpv 17 
homozygotes (Figure 7 .3) for changes in the collagenase IV protein 
level by immunohistochemistry. Figure 7.3 shows that MMP-2 is 
increased in the glomeruli of the Mpv 17 mice. Even if this increase is 
not dramatic, it supports the hypothesis that enhanced MMP-2 
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Figure 7.1 Northem blot of fibroblasts expressing reciprocal amounts of Mpv17 and 
MMP-2 transcripts. Lane 1-3: Poly A+ RNA from three different immortalised skin 
fibroblast lines from Mpv17 homozygous mice. Lane 4-6: Poly A + RNA from NIH3T3 
cells expressing varying amounts ofthe Mpv17 transcript. Lane 7 and 8: Poly A+ RNA 
from RSV1 and RSV7 cells (Zwacka et al., 1994). 
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Figure 7.2 Northern Blot of immortilized skin fibroblasts from Mpv17 homozygous 
animals treated with HzOz. The expression of MMP-2 is shown at several time points 
after the treatment of the cells with HzOz (C=O rninutes). 
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Figure 7.3 Immunohistochemistry of frozen sections from a heterozygous Mpv 17 
mause (top) and a homozygous Mpv17 animal (bottom) probed with an anti-human-
MMP-2 monoclonal antibody that cross reacts with the mause protein (ldndly provided 
by Dr. Matti Höyhtyä, Oulu). The primary antidody was detected by the alkaline 
phosphatase anti-alkaline phosphatase (APAAP) immune complex revealing a pink 
colour, while cell nuclei are blue due to staining with hematoxilin. 
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Chapter 8. Rescue of the Mpv17 phenotype by transgenesis 
The Mpv17 genewas identified by cloning the pre-integration site of the 
provirus used for the generation of the mutant mice. The expression of 
the Mpv 17 gene was found to be completely abolished by this 
integration. The Mpv17 gene is therefore the prime candidate for a 
recessive disease gene causing glomerulosclerosis. The human 
homologuc, wc have identified, isolated, and studied (Karasawa et al., 
1993) is highly conserved, indicating an important role in the 
maintenance of proper kidney function. Moreover, the Mpv17 genewas 
the only nonrepetitive and conserved region in the vicinity of the 
proviral integration (Weiher et al., 1990). In accordance with the notion 
that a provirus only affects regulatory elements or genes close to the 
insertion it was assumed that the Mpv 17 gene, whose loss of function is 
causal to the disease. However, it could not be ruled out completely that 
another, possibly more distant gene, besides Mpv17, is affected in the 
mouse genome by the provirus, thereby actually causing the renal 
disorder. The only definitive experiment to prove that the silenced 
Mpv 17 gene Ieads to the kidney disease is the rescue of the phenotype by 
introducing the wild type gene into the germline or by targeted 
inactivation of the gene. 
Transgenie construct 
W e decided to take the rescue approach and introduced the human 
Mpv17 gene under the control of a heterologous promoter as a 
transgene into the germline of mice. I therefore placed the gene as a 
cDNA containing one homologaus intron of 263bp length (Karasawa et 
al., 1993) as weil as the 3" untranslated region with its polyA sequence 
under the control of the mouse metallothioneine I promoter (kindly 
provided by Dr. Erwin Wagner, IMP, Vienna). The construct carrying 
the intron between exon 6 and exon 7 had been isolated as an 
incompletely spliced cDNA in the process of cloning the human Mpv17 
cDNA (Karasawa et al., 1993). This molecule was used for the 
generation of transgenic mice because it has been reported that introns 
increase the expression of transgenes in general (Brinster et al., 1988; 
Choi et al., 1991). Secondly it allows the discrimination of amplified 
cDNA representing transgene transcripts from artefacts due to 
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contamination of the isolated mRNA with genomic DNA on the basis of 
the size of the amplification products, when transgene expression is 
analysed by Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR). The mouse metallothioneine I promoter (MT-I) contained on a 
1.8 kb fragment has been shown to successfully drive the expression of 
transgenes in kidney and liver (Hamer, 1986). Figure 8.1 depicts the 
construct used for microinjection. (microinjections were performed by 
Dr. Johannes Schenkel in our laboratory). This isolated DNA fragment 
was injected into the pronuclei of zygotes of female Balb/c mice mated 
to male Balb/c or Mpv17 mice (the latter are on a CFW/Balb/c 
background). 
Identification of transgenic animals 
The mice resulting from microinjections were tested for the integration 
of the construct DNA by Southern blot analysis of tail DNA. The tail 
DNA was cleaved with Sac I restriction endonuclease, Southem blotted, 
and hybridised to the radiolabelled human cDNA fragment. From the 
initial 10 candidates one (# 670) was found tobe positive for a transgene 
insertion and subjected to further analysis. The transgene was detected 
as a fragment of 1.2 kb as shown in Figure 8.2 (TG). The second upper 
transgenic band is probably due to transition fragments that are 
generated at the border of the transgene integrate by loss of the Sac I 
site flanking the construct at its 3" end. Taking this into account, the 
number of tandem transgene copies in this strain was estimated to be 
about 15, judging from the intensity of the transgene specific band. 
Despite stringent hybridisation conditions, the endogenous mouse Mpv 
17 locus cross hybridises with the human cDNA as shown in Figure 8.2 
(EG). Meanwhile, two other transgenic founders have been generated 
using the same construct and they are currently being examined. 
However, none of these three strains displayed any obvious phenotype. 
Animals originating from the transgene animal 670 were mated into the 
homozygous Mpv17 background. This is possible because Mpv17 
homozygotes are fertile and live long enough to reproduce. The mutant 
endogeneaus allele can be followed in these breedings by use of a 
polymorphism between the wild type and mutated alleles described in 
Weiher et al. (1990). The genomic probe, a Sau 3A fragment of about 
350 bp, detects a 3 kb fragment in the wild type (WT in Figure 8.2) and 
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a 6 kb fragment in the mutated allele (MA in Figure 8.2) on Bam HI 
digested DNA. Thus, heterozygous animals show both the WT and the 
MA band, whereas hybridistaion only to the MA band indicates 
homozygosity for the mutation. The initial breeding of the mouse670 
with Mpv 17 homozygous mice resulted in heterozygotes which were 
further interbred, and the genotype of the F2 generation was analysed. 
Homozygous animals also carrying the MT-Mpv17 transgene were again 
interbrcd and this newstrainwas designated MT670. 
Survival and histological analysis of MT670 
So far, about 50 animals of this particular genotype have been 
generated, of which none died of or developed signs of nephrotic 
syndrome. Thus, the transgene obviously affects the survival of the 
mice. In order to analyse whether the presence of the transgene actually 
prevents the MT670 mice from developing glomerulosclerosis, several 
animals were sacrificed at the age of six months and the kidneys were 
histologically analysed. A standard Periodic-acid Schiff (PAS) staining 
is shown in Figure 8.3, demonstrating sclerosis in homozygous Mpv17 
mice while heterozygous control animals, as weil as the MT670 rescue 
mouse strain, show no abnormalities in their kidneys. Hence, at the level 
of kidney pathology, successful rescue of the Mpv17 phenotype, 
depending on the presence of the transgene, could be demonstrated. 
Expression of the transgene in kidney 
In order to explain the complementation of the Mpv 17 phenotype we 
examined transgene expression in kidneys of MT670 and control 
animals. Isolated poly A + RNA from rescue and homozygous animals 
was subjected to RT-PCR. In addition, control RNAs from the human 
fibroblast cell line GM 637 and RSV7 cells were analysed. For 
comparison, the PCR products derived from the human cDNA and the 
intron-containing construct used for microinjection was examined 
(Figure 8.4 ). The primers used in this analysis specifically detect 
transgene-derived transcripts, because they were chosen from the 5" and 
3" untranslated regions of the human cDNA, respectively, where the 
murine and human sequences significantly differ (Karasawa et al., 
1993). A product of the expected size of 585 bp representing authentic, 
fully spliced mRNA was detected in the sample from the MT670 mouse 
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(lane 6). This corresponds with bands of the same size in samples from 
GM 637 cells (lane 7), from RSV7 cells (lane 8) and with the PCR 
product from the fully spliced cDNA construct (lane 9). By contrast, no 
expression was detected in non-transgenic Mpv 17 homozygotes (lane 5) 
and PCR of the transgenic construct resulted in a bigger product of 
about the expected size of 848 bp (lane 10). This proves that the 
amplification products do not result from contaminating genomic DNA 
in lhe RNA preparations, as the transgene represents a cDNA in which 
intron 6 of 263 has not been removed. Amplification of genomic DNA 
from MT670 mice would therefore result in a larger fragment (848 bp) 
as shown in the control reaction (lane 10). These results demonstrate 
transgene expression in the kidney of IviT670 mice, and we conclude 
that the expression of the human homologue in these mice complements 
for the loss of Mpv 17 function in homozygous Mpv 17 mice. This 
functional rescue not only proves that the Mpv 17 phenotype is caused by 
the loss of function of the Mpv 17 gene, but is also evidence for the 
functional homology of the two genes in mouse and man, stressing the 
potential role of the Mpv 17 gene in human kidney disease. 
The transgene technology could be used in further experiments to 
address the question in which tissue the primary injury, leading to the 
kidney deficiency, might occur. Constructs directing Mpv 17 expression 
to different target tissues could be used for this purpose. 
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Figure 8.1 The human MT Mpv17 rescue gene construct. The human Mpv17 cDNA 
gene including intron 6 (Karasawa et al., 1993) is under control of the mause 
metallothioneine (MT) promoter. The 3 kb BssHI restriction fragment was used for the 
generation of transgenic mice. 
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Figure 8.2 Genotyping of transgenic mice. Southem blot analysis of tail DNA of the 
transgenic mice. Top panel: Endogenaus Mpv17 locus: BamH1 cleaved DNA was 
hybridised with a 350bp Sau 3A fragment diagnostic for the mutation (Weiher et al., 
1990); WT: wt Mpv17 allele; MA: mutated Mpv17 allele. 
Lower Panel: Presence of the MT -Mpv17 transgene: Sac I digested DNA was 
hybridised with a fragment representing the human cDNA. TG: transgene fragment. 
EG: crosshybridising endogenaus Mpv17 locus. The kidney histology of mouse 5 
(homozygous mutant Mpv 17; transgenic for MT-Mpv 17) and mouse 2 ( heterozygous 
Mpv17 mouse) are shown in Figure 8.3. The control homozygous mutant animal is not 
depicted on this Southem blot. 
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Figure 8.3 Representative histology (PAS stain) of six months-old mice with 
different Mpv17 genotype. a (x140) and b (x550): heterozygous Mpv17; c (x140) and 
d (x430): homozygous mutant Mpv17 mice demonstrating an early stage of glomerular 
sclerosis; tubular interstitial changes have not yet developed; e (x270) and f (x550): 
strain MT670 (homozygous mutant Mpv 17, transgenic for MT-Mpv 17. 
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Figure 8.4 Analysis of the transgene expression. Transgene expression was 
examined using the RT-PCR technique on polyA+ RNA ofkidneys from different mice: 
Lanes 1 and 5: homozygous mutant Mpv17 mouse. Lanes 2 and 6: MT670 mouse 
(mouse 5 in Fig.2). Lanes 3 and 7: human GM637 fibroblasts. Lane 4 and 8: RSV 7 
cells. Lanes 1 to 4: reverse transcriptase was omitted from the RT -PCR protocol as 
control for DNA contamination. Lanes 5 to 8: complete RT-PCR protocol. Lane 9: 
amplification on the human cDNA clone p21 (Karasawa et al., 1993). Lane 10: 
amplification on the MT -Mpv17 rescue construct, containing intron 6. For correctly 
spliced transgene derived mRNA a product of 585bp is expected (lane 9). Unspliced 
transgene mRNA or contaminating transgene DNA results in a fragment of 848 bp (lane 
10). 
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Chapter 9. Discussion 
In cantrast to the transgenic mause lines that serve as animal models for 
glomerulosclerosis, in which overproduction of a transgene dominantly 
causes the phenotype (listed in Table 1.2), the Mpv17 strain is a 
recessive mutant. Thus, lass of function of a gene at the Mpv 17 locus 
causes the disease. An integration of a retroviral genome into a gene at 
the Mpv17 locus, the Mpv17 gene, suggested that loss of this function 
was responsible for the development of the phenotype. The isolation and 
analysis of a human homologue of this gene is described here, and 
reveals a high conservation of this single copy gene between humans and 
mice. Besides the structural hornology, functional equivalence was also 
demonstrated, in that the human Mpv 17 gene under the control of a 
heterologous promoter can cornplement the phenotypic defect . of the 
rnutant rnice (Schenkel et al., 1995). This proves that the lack of Mpv17 
expression in the mutant mice is responsible for the phenotype, and 
suggests that mutations in the human gene may also lead to inherited 
glomerulosclerosis in man. 
The best characterised and most frequent clinicopathological entity of 
familial glomerulosclerosis is the Congenital N ephrotic syndrome of the 
Finnish Type (CNF). Wehave so far, however, found no mutations of 
the Mpv17 gene in such patients. Furthermore, our chromosomal 
localisation of the human gene to chromosome 2 (Karasawa et al., 1993) 
and the chromosomal assignment of the CNF locus to chromosome 19 
by Kestilä et al. (1994a) make a causal role of the Mpvl7 gene in CNF 
unlikely. A potential role for Mpv17 in other inherited kidney diseases 
is presently under investigation. It is likely that mutations in more than 
one gene can lead to glomerulosclerosis, and once such genes have been 
isolated, it will be interesting to study if at least some of their gene 
products act in a single pathway identified by the Mpv17 mutation. 
The Mpv 17 gene codes for a protein of 17 6 amino acids in both humans 
and mice, barbauring several potential membrane spanning regions. It 
shows a 54% sequence homology to the peroxisomal membrane protein 
22 (pmp22). The comparision between the pmp 22 and Mpv17 
membrane-topologic profiles suggests that both aretype IIIb membrane 
proteins. These similarities suggest that these proteins might have an 
analogaus localisation and possibly related functions. To address these 
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questions, I raised antiborlies against the human Mpv 17 protein and 
determined its intracellular localisation by immunofluorescence. The 
Mpv 17 protein does indeed localise to the peroxisome, raising the 
question whether the Mpv17 protein is involved in human peroxisomal 
disorders. 
The most severe of these peroxisomal diseases, classified as Zellweger 
syndrome, is characterised by structural defects leading to the loss of 
function of the whole organelle. I thereforc investigated if Mpv17 
negative mice are deficient in peroxisome biogenesis. We found, 
however, that these mice exhibit completely normal peroxisome 
formation indicating that Mpv17 is not involved in peroxisomal 
assembly. Considering the peroxisomal localisation of the !\1:pv 17 
protein one might expect that glomerulosclerosis would be one of the 
various disease parameters ZS patients display. However, this is not the 
case. This apparent contradiction might be explained by the early 
lethality of Zellweger syndrome, which may not allow for the 
development of the glomerulosclerosis phenotype. Interestingly, for 
most Zellweger patients an involvement of the kidney is reported which 
is described as rnicrocysts (Lazarow and Moser, 1989). Similar 
pathology is often found in the Mpv17 homozygous mice. 
Most other peroxisomal diseases involve defects of single metabolic 
pathways taking place in this organelle. W e therefore screened for the 
physiological parameters characteristic for theses diseases and found no 
abnormalities in very long chain fatty acid (VLCF A) degradation, bile 
acid formation, and plasmalogen synthesis. Again, no differences were 
seen between mutant and control animals. It is therefore possible that I 
have identified a new functionallink between a peroxisomal defect and a 
glomerular disease. 
One of the most prominent functions of peroxisomes is the production 
and degradation of reactive oxygen species (ROS), in particular the 
superoxide anion 0 2-. Prompted by numerous reports on the damaging 
effect of ROS on basement membranes and their role in 
glomerulosclerosis (Wardle, 1992), I investigated the oxidative status of 
cells from homozygous Mpv 17 and control mice. Much to my surprise, 
I discovered that the Mpv17 gene product is involved in the production 
of ROS as homozygous cells show less, not more ROS. Moreover, the 
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Mpv17 gene itself when transfected into murine fibroblasts exhibits a 
ROS-producing activity. 
The ROS-producing activity of the Mpv17 protein is distinct from other 
enzymatic mechanisms known to produce ROS in mammals, namely 
NADPH oxidase and xanthine oxidase (XO, Cross and Jones, 1991). The 
NADPH oxidase in neutrophils consists of several membrane bound 
proteins and is responsible for the respiratory burst crucial for 
phagocytotic dcfcnsc mechanisms. Mutations in this TPA~inducible 
system in humans lead to chronic granulomatosis disease (CGD; Smith 
and Curnutte, 1991, Royer-Pokora et al., 1986). Based on its protein 
sequence and intracellular localisation, however, Mpv17 must be distinct 
from this system. Xanthine oxidase (XO) is a peroxisomal enzyme 
producing Or radicals upon oxidation of xanthine to urate. Structurally, 
Mpvl7 is distinct from this enzyme and the phenotype of XO deficiency 
does not involve the kidney, making a role of Mpv17 in this pathway 
unlikely. Therefore, although it is not yet formally possible to exclude 
interactions between Mpv17 and the two ROS-producing pathways, I 
favour the hypothesis that Mpv 17 acts in a yet unidentified oxidation 
mechanism. 
These results prompted me to reconsider the role of reactive oxygen in 
the Mpvl7 system. In contrast to my initial hypothesis, according to 
which high ROS levels directly impose darnage onto the glomerular 
basement membrane, I now have to postulate that low ROS levels cause 
regulatory changes within cells which are relevant for kidney damage. 
The first prerequisite of this postulate would be that Mpv17 expression 
controls the expression of other genes mediated by the increase of ROS 
levels. In fact, in stable transfectants of Mpv 17 expression vectors I can 
observe such effects. Most interestingly, the gene for the 72 kD form of 
type IV collagenase (MMP-2) is strongly expressed in cells lacking 
functional Mpv 17 protein while it is repressed in cells overproducing 
Mpv17. The MMP-2 protein is of particular interest in the context of 
glomerulosclerosis, since it has been shown that the development of this 
disease in experimental animal models is accompanied by enhanced 
expression of MMP-2 in the glomerulus (Nakamura et al., 1994). MMP-
2, as a member of the matrix metalloproteinase family, has a crucial 
function in the degradation of type IV collagen which is the major 
component of the glomerular basement membrane (GBM). Thus, 
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upregulation of this enzyme could potentially inflict darnage directly to 
the GBM. Suchinitial injury would result in the gradualloss of function 
of the respective glomerulus. This proposed mechanism represents an 
attractive explanation of the observed data, including the focal and 
segmental appearence of the phenotype (Weiher et al., 1990). 
This model requires a number of testable prerequisits. First, if the lack 
of Mpv 17 is important directly at the level of GBM tumover, Mpv17 
expression should be detectablc in the cells involved in these processes. 
In fact, I have observed Mpv17 expression in podocytes, the cell type 
chiefly responsible for GBM synthesis and degradation (Glassock et al., 
1991; Johnson et al., 1992). Second, MMP-2 expression is expected to 
be enhanced in the absence of Mpv 17 protein not only in fibroblasts but 
also in the glomerular epithelial cells. Indeed, such enhanced Ievels were 
detected by immunohistochemistry in the glomeruli of Mpv17 
homozygotes. 
If the Mpv17 gene acts as a general regulator of ROS levels in cells, the 
question arises, why a failure to express this almost ubiquitously 
expressed gene causes such a specific phenotype. This seemingly 
paradoxical phenomenon could be resolved when one consides that many 
widely expressed genes produce specific 'knock out~ phenotypes. The 
ß2-microglobulin negative mice are an example of such an effect 
(Zijelstraa et al, 1989). In addition, there may be several overlapping 
ROS producing functions which are able to complement each other in 
most cell types. The apparent specificity of the Mpv 17 phenotype would 
then be the result of a cell type specific lack of redundancy of these 
regulatory systems. 
The Mpv 17 mouse model has served as a valuable model to study the 
molecular mechanisms that can lead to glomerulosclerosis. The isolation 
of the affected gene has enabled us to reveal a new connection between 
intracellular ROS levels, gene expression, and the pathology of kidney 
disease. In the future it should provide a system in which a more 
detailed elucidation of the glomerulosclerosis pathway can be achieved. 
This in return could reveal new approaches to the diagnosis and 
treatment of this disease. 
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